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 One key signaling pathway in the cellular signaling involving G protein coupled 
receptors (GPCR) is via heterotrimeric G proteins. The first step in GPCR/G protein 
signaling is the activation of a GPCR by the ligand binding and the next step is the 
activation of the G protein. Understanding the molecular mechanism behind the GPCR/G 
protein interactions will help in characterizing this important signaling pathway and 
should ultimately lead to the design of functionally selective ligands for this larger class 
of receptors. Earlier, the Reggio group used molecular dynamics simulations to study the 
activation of the cannabinoid CB2 receptor, a class A GPCR, by its endogenous ligand, 2-
arachidonoylglycerol (2-AG) via the lipid bilayer. The goal of the current project was to 
study the next step in the G-protein mediated signal transduction, when an agonist 
activated CB2 receptor forms a complex with Gi protein and catalyzes the activation of Gi 
protein, releasing the guanosine diphosphate (GDP) bound between the ras-like (also 
known as GTPase domain) and helical domains of the Gα protein. To this end, we report 
here the CB2 / Gαi1β1γ2 complex formation using our 2-AG activated CB2 receptor 
model.  For G protein activation (dissociation of GDP), we hypothesized that GDP 
release from the ras-like and helical domains of Gαi would be triggered by the hydration 
of GDP. We probed the role of the CB2 receptor interactions with the Gαi protein and the 
resultant progression of GDP hydration. We have seen the number of waters surrounding 
GDP increase from 16 (t= 0 ns) to 28 waters (t=5 μs). Two important interactions 
between the receptor and G-protein appear to lead to the increased hydration of GDP. (1) 
 
 
A hydrophobic interaction occurred between CB2 IC2 loop residue P139 and the Gαi 
hydrophobic pocket residues: V34 (N terminus; L194 (β1 sheet); F196 (β2 sheet); and, 
F336, T340, I343, I344 (α5 helix) multiple times in our 5 μs long trajectory. Each time 
this interaction occurred, an increase in GDP hydration was observed in our simulation. 
2) We also observed an IC3 loop interaction with the Gαi α4 helix between 1.4 to 1.6 μs, 
in which the IC3 loop residue R229 reached to interact with E297 and E298. Taken 
together, our results show that the intracellular loops play a critical role in the hydration 
of GDP that should lead to G protein activation.  
 GPCRs exist as dimers also and there is not much known concerning CB2 receptor 
dimerization. We investigated the dimer interface for the cannabinoid CB2 receptor; two 
residues on TMH6 A6.60C and H6.57C were identified to be part of the CB2 homodimer 
interface by our collaborator, Dr. Zhao-Hui Song using substituted cysteine accessibility 
method (SCAM). Our molecular dynamics studies of 2 independent trajectories (500 ns 
each) confirm the involvement of the residues A6.60 (270) and H6.57 (267) in the 
formation of the CB2 active/ inactive homodimer interface.
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CHAPTER I 
STRUCTURAL BASIS OF G PROTEIN-COUPLED RECEPTOR- Gi PROTEIN 
INTERACTION: FORMATION OF THE CANNABINOID CB2 RECEPTOR / Gi 
PROTEIN COMPLEX 
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Abbreviations: GPCR – G protein-coupled receptor, CB2 – Cannabinoid Receptor Sub-
type 2, R – Inactive receptor, R* - Activated receptor, 2AG – sn-2-arachidonoylglycerol, 
POPC–  1-palmitoyl-2-oleoyl-phosphatidylcholine, 2-AR – beta-2-adrenergic receptor, 
MD – Molecular Dynamics, EC – Extracellular, IC – Intracellular, TMH – 
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LCMS – Liquid Chromatography- Mass Spectrometry 
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Abstract 
 In this study, we applied a comprehensive G protein-coupled receptor - Gi, 
protein chemical cross-linking strategy to map the cannabinoid receptor subtype 2 (CB2) - 
Gαi interface and then used molecular dynamics simulations to explore the dynamics of 
complex formation. Three crosslink sites were identified using LC MS/MS and 
electrospray ionization (ESI)-MS/MS as follows: (1) a sulfhydryl crosslink between 
C3.53 (134) in TMH3 and the Gi, C-terminal i-3 residue, C351; (2) a lysine crosslink 
between K6.35 (245) in TMH6 and the Gi, C-terminal i-5 residue, K349; and (3) a 
lysine crosslink between K5.64 (215) in TMH5 and the  Gi α4β6 loop residue, K317. 
  To investigate the dynamics and nature of the conformational changes involved in 
CB2-Gi complex formation, we carried out microsecond-timescale molecular dynamics 
(MD) simulations of the CB2 R*/ Gαi1β1γ2 complex embedded in a 1-palmitoyl-2-oleoyl-
phosphatidylcholine (POPC) bilayer, using crosslinking information as validation. Our 
results show that although MD simulations started with the G protein orientation in the 
β2-AR*/ Gαsβ1γ2 complex crystal structure, the Gαi1β1γ2 protein re-oriented itself within 
300 ns.  Two major changes occurred: (1) The Gαi1 5 helix tilt changed due to the 
outward movement of TMH5 in CB2 R*.  (2) A 25
0 clockwise rotation of Gαi1β1γ2 
underneath CB2 R* occurred, with rotation ceasing when P139 (IC2 loop) anchors in a 
hydrophobic pocket on Gαi1 (V34, L194, F196, F336, T340, I343 and I344).  In this 
complex, all three experimentally identified crosslinks can occur. These findings should 
be relevant for other Class A GPCRs that couple to Gi proteins.  
3 
 
Introduction 
 G protein coupled receptors (GPCRs) represent excellent drug targets because 
they are involved in regulating nearly all known physiological functions (1,2). Class A 
GPCRs are thought to have a common topology that includes an extracellular N-
terminus, a transmembrane core formed by a bundle of seven transmembrane α-helices 
(TMH1–7), three extracellular (EC) and three intracellular (IC) loops that connect these 
helices, and, an intracellular C-terminus that begins with a short amphipathic helix lying 
parallel to the membrane (3-6). Physiologically, GPCRs are activated by ligands 
(extracellular and membrane based) that enable the receptors to interact with and activate 
distinct sets of heterotrimeric G proteins (Gαβγ), as well as -arrestins (7,8).  
Specifically, ligand-activated GPCRs catalyze the exchange of GDP for GTP on the Gα 
subunit. GTP binding to Gα is predicted to trigger the dissociation of the heterotrimeric G 
protein into Gα-GTP and free βγ, which are then able to modulate the activity of a 
multitude of downstream effectors including adenylate cyclase and ion channels, such as 
G protein gated inwardly-rectifying potassium (GIRK2, GIRK4) channels, phospholipase 
Cβ and plasma membrane Ca2+ pumps (9-12). 
 The CB2 receptor belongs to Class A of the GPCRs and is mainly expressed in T 
cells of the immune system (13) and the gastrointestinal system (14,15).  CB2 has also 
been reported to play an important role in central immune responses during neuropathic 
pain in mice (16). We have previously performed microseconds long MD simulations of 
the CB2 endogenous ligand, sn-2-arachidonoylglycerol (2-AG), entering and activating 
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CB2 via the lipid bilayer (17). Activation of CB2 has been shown experimentally to 
produce coupling to Gαi inhibitory protein (18-20).  Although a significant amount of 
information is available for GPCR catalyzed activation of G proteins (21), many atomic 
level details concerning complex formation and signal transduction remain unanswered.  
 In this work, we studied the formation of a CB2R*/ G protein complex both 
experimentally and computationally.  Systematic cross-linking experiments were 
performed using HgCl2 and a short bi-functional, irreversible chemical crosslinker 
disuccinimidyl suberate (DSS). These studies yielded three specific contact sites between 
CB2 and Gαi1 protein, providing new insights into the molecular architecture of the CB2 
and Gαi1 interaction. Then, in order to place these crosslinks in a structural perspective 
and also to explore the dynamical formation of the CB2R*/ Gαi1β1γ2 complex, we 
undertook two independent microsecond-long molecular dynamics simulations of the 
CB2R*/ Gαi1β1γ2 complex in a POPC bilayer. These studies revealed a stepwise formation 
of the complex that brings all crosslinked pairs into spatial proximity. 
Methods  
Cell Transfection and Culture  
 Human Embryonic Kidney 293 (HEK293) cells were maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, 
100 units/ml penicillin, and 100 g/ml streptomycin in a humidified atmosphere 
consisting of 5% CO2, at 37°C. Expression plasmids containing the N-terminal FLAG 
peptide (DYKDDDDK) tagged human CB2 cannabinoid receptors were stably transfected 
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into HEK293 cells using Lipofectamine, according to manufacturer’s instructions. Stably 
transfected cells were selected in culture medium containing 800 g/ml geneticin. Having 
established cell lines stably expressing FLAG-CB2 receptors, the cells were maintained in 
growth medium containing 400 g/ml of geneticin until needed for experiments.  
Crosslinking Reactions and Purification of the Crosslinked Protein Complex 
 The CB2 receptor has been shown to exhibit high constitutive activity (19).  For 
this reason, crosslinking experiments were conducted in the absence of exogenous 
agonist. For each crosslinker, the crosslinking reactions were performed according to 
manufacturer’s instructions. Briefly, cells expressing FLAG-CB2 receptors were collected 
and cell membranes were prepared as previously described (22) in 20 mM HEPES buffer 
containing 150 mM NaCl. After adding cross linkers at a final concentration of 2 mM, the 
cell membranes were incubated on ice for 2 hours. At the end of incubation, the cross 
linking reactions were terminated by adding quench solutions. Subsequently, Triton-X100 
was added to a final concentration of 1% and the membrane suspension was incubated at 
4 °C for 2 hours by end-to-end gentle rotations. The suspension was then centrifuged at 
100,000g for 1 hour at 4 °C to remove unsolubilized particles. For anti-FLAG M2 affinity 
chromatography, the solubilized suspension was incubated with 0.5 ml of anti-FLAG M2 
agarose affinity gel at 4 °C for 2 hours with gentle rocking. After extensive washing with 
20 mM HEPES containing 150 mM NaCl and 1% Triton X-100, the bound CB2 was 
eluted with 8-column volumes of 0.1 mM glycine HCl, pH2.5 containing 1% Triton X-
100. 
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In-gel Digestion 
 The purified CB2 complex was resolved by SDS-PAGE and then subjected to 
Western blot and Coomassie Blue staining. Both anti-CB2 antibody and anti-G protein 
antibody was used to identify the band corresponding to the CB2-G protein complex. The 
CB2-G protein complex band was then excised from Coomassie blue stained gel and 
subjected to enzymatic digestions according to a published protocol (22,23) with slight 
modifications. Briefly, the bands were cut into small pieces, destained with 50 mM 
NH4HCO3/acetonitrile (1:1, v/v), and digested with 10 ng/μl pepsin overnight.  
ESI-MS/MS 
 Peptides from the enzymatic digests were analyzed by ESI-MS/MS as described 
previously (22). Briefly, peptides from the enzymatic digests were condensed to 1–2 μl 
with a Speedvac, diluted with 5 μl of 0.2% trifluoroacetic acid (TFA), and analyzed by a 
Waters CapLC coupled to a Q-TOF API-US mass spectrometer (Waters, Milford, MA). 
The samples (5 μl) were injected onto a 300 μM × 5 mm PepMap C18 precolumn (LC 
Packing, Sunnyvale, CA), washed with 5% ACN in 0.1% formic acid at 30 μl/min for 
3 min, eluted onto and separated with a 75 μM × 150 mm Atlantis dC18 analytical 
column (Waters, Milford, MA). Separation was started with a 5 min isocratic elution with 
95% solvent A (5% ACN with 0.1% formic acid) and 5% solvent B (95% ACN with 0.1% 
formic acid) and followed by a linear gradient from 5% solvent B to 40% solvent B over 
115 min and then from 40% solvent B to 60% solvent B in 30 min. The flow rate on the 
column was about 200 nL/min. The eluted peptides were directed to a Q-TOF API-US 
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mass spectrometer with a nanoflow source and MS and MS/MS spectra were acquired by 
Data Dependent Scan.  
 Data analyses were performed with the aid of on-line server MS3D (24,25). First, 
the precursor peptide ions from LC-MS/MS were screened by the “Links” program from 
MS3D. Links calculates the theoretical crosslinking possibilities for CB2-G protein 
complex, with information provided about the crosslinkers and protease used and the 
expected amino acid modifications. The Links program then gives us putative 
assignments within a defined mass error threshold for a list of input mass (MH+) values. 
Once the candidates of CB2-G protein crosslinked peptides were obtained, each candidate 
peptide was further analyzed by the “MS2Links” program from MS3D. MS2Links is a 
program for assigning tandem MS peak lists generated from the fragmentation of 
crosslinked, modified or unmodified peptides. MS2Links calculates the theoretical 
MS/MS fragment library given information about the identity of the base ion, 
crosslinkers, desired ion types, and amino acid modifications. MS2Links then returns 
assignments within a defined mass error threshold for the list of input mass (MH+) 
values. 
CB2 Receptor Model 
 The CB2 model employed here was taken from our previous microsecond-long 
simulation of the activation of the CB2 receptor by the endogenous ligand, 2-AG, via the 
lipid bilayer (17).  In this simulation, the ionic lock at the IC ends of TMH3-TMH6 
(R3.55-D6.30) was broken within 3 ns of 2-AG head group entry between TMH6 and 
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TMH7 from the lipid bilayer (POPC). To represent the CB2 activated state, we chose 
coordinates corresponding to time point 184.138 ns from trajectory E in which the salt 
bridge between TMH3 and TMH6 is broken (17). The α-carbon distance between R3.55 
(136) and D6.30 (240) was 15.2 Å and the heteroatom distance N (R3.55 (136)) – O 
(D6.30 (240)) was 12.7 Å (17). In this bundle, the C-terminus contains the palmitoylation 
site at C320 and was truncated after G322. 
G Protein Modeling 
 For this study, the crystal structure of Gαi1β1γ2 (26) was used to dock with CB2 
R*. The extreme Gαi1 C-terminus is unresolved in this structure, so the undecapeptide 
NMR structure (27) of this region in Gαt was grafted onto the backbone of residues 
K345, N346 and N347 (see Discussion section). The C-terminus of Gγ2 is also 
unresolved in the Gαi1β1γ2 structure.  This region was built by homology modeling using 
the NMR structure of Gγ1 (28) as template and the Maestro module from Schrodinger, 
LLC, New York, NY.  
Lipidation Sites  
 Palmitic acid was attached to the N-terminus of Gαi1 at Cys3 (29).   Myristic acid 
was attached to Gly2 of Gαi1 (30) and a geranylgeranyl group was attached to Cys 68 in 
the Gγ2 C-terminus (31).   
CB2/Gi-Protein Complex 
 The relative orientations of CB2 R* and Gαi1β1γ2 were based on the β2-AR / 
Gαsβ1γ2 complex crystal structure (32). To get relative receptor position, first the 
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activated CB2 receptor was superimposed on the α carbon atoms of the residues N1.50, 
D2.50, R3.50 and W4.50 on the β2-AR receptor from the β2-AR / Gαsβ1γ2 complex. To 
obtain the relative orientation of Gαi1β1γ2 heterotrimer with the CB2 receptor, Gβ1 of 
Gαi1β1γ2 was superimposed on the α carbon atoms of residues from 51 to 340 of Gβ1 in 
the Gαsβ1γ2 protein from the β2-AR / Gαsβ1γ2 complex. To relieve steric clashes between 
CB2 and Gαi1, the whole Gαi1β1γ2 heterotrimer was translated in the z-direction. 
Construction of CB2/Gαi1β1γ2 Complex in POPC Bilayer 
 The CB2 R*/G protein complex was aligned such that the transmembrane region 
of the CB2 receptor was centered at the middle of the POPC lipid bilayer and the 
amphipathic helix 8 was oriented parallel to the plane of the membrane at approximately 
the lipid/water interface. The model membrane simulation cell was constructed with the 
replacement method, using scripts derived from CHARMM-GUI (33). The CHARMM22 
protein force field with CMAP corrections (34,35) and the CHARMM 36 lipid force field 
(36) were used in this study. Parameters for GDP were obtained by analogy to ADP using 
the nucleic acid force field (37) and those for 2AG were derived from the lipid force field 
(17, 36). The lipidation sites are covalent modifications of their respective amino acids. 
The parameters for the palmitoylation sites were taken from our earlier simulations (17). 
Parameters for the myristoylation of Gαi and prenylation of the Gγ2 covalent linkages 
were taken by analogy with existing CHARMM force field parameters. Given that the 
primary role for these lipidation sites in these simulations is to anchor their respective 
proteins to the lipid matrix, no further optimization was performed. Charge neutrality was 
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enforced with addition of chloride counter ions and an overall ionic strength of 0.1M was 
obtained by adding NaCl. The final system contained 451 POPC lipid molecules, the 
protein complex, ions, and solvating water molecules with a simulation cell size of 130.0 
Å x 130.0 Å x 170.6 Å.  
 
Initial Minimization and Equilibration 
 To relieve poor initial contacts, 500 steps of steepest descent minimization was 
performed using CHARMM (38), with all heavy atoms of the protein complex fixed. 
This was followed by 20,000 steps of conjugate gradient minimization using NAMD 
(39). The fully minimized system was heated in 10 K increments to 310 K with restraints 
on the protein (force constant of 10 kcal/mol/Å2 / 5.0 kcal/mol/Å2 for the 
backbone/sidechains and ligands respectively), on the POPC phosphates (force constant 
of 5.0 kcal/mol/Å2), and a harmonic dihedral restraint on the POPC cis double bond and 
the glycerol c2 chiral center (force constant of 500 kcal/mol/rad2). At each increment, 
500 steps of minimization were performed followed by 20 ps of dynamics at the higher 
temperature. Equilibration was continued for 100 ps of molecular dynamics and then the 
restraints were released in 6 steps over 1.5 ns. 
Details of Molecular Dynamics Simulations 
 For all production runs, NAMD (39) was used. Long range electrostatics were 
included using PME (40) with a 10 Å short range cutoff and van der Waals interactions 
were treated with a switching function and a 10 Å cutoff. The NPT ensemble, as 
implemented in NAMD, was used to maintain temperature (T=310 K, damping 
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coefficient of 2 ps-1) and pressure (P=1.01325 bar, piston period/decay of 100/50 fs). 
High frequency bonds to hydrogen were restrained using the shake method implemented 
in NAMD allowing a 2 fs integration time step. Production dynamics was performed on a 
Blue Gene supercomputer (41) located at the Thomas J. Watson Research Center and on 
the BSBC cluster at UNC Greensboro (http://bsbc.uncg.edu/index.html). Two separate 
trajectories were run for this complex. Results from these trajectories each at 1 µs in 
length are reported here. All analysis were performed using visual molecular dynamics 
(42) and LOOS (43). 
Measuring the Angle of Rotation for Gαi1β1γ2 Relative to the CB2 Bundle 
 To measure the rotation of the G protein under the CB2 receptor throughout the 
trajectories, the CB2 receptor TMH bundle for each nanosecond of Trajectory 1 and 
Trajectory 2 was superimposed on the transmembrane region of the CB2 receptor starting 
structure (t=0 ns). The atoms used for the superposition were K1.32 (33) to S1.59 (60), 
P2.38 (68) to N2.63 (93), A3.23 (104) to R3.55 (136), R4.39 (147) to M4.62 (170), D5.38 
(189) to K5.64 (215), L6.33 (243) to A6.60 (270) and K7.33 (279) to R7.56 (302). Two 
centers of mass were calculated: (1) the center of mass of Gα ras-like domain (GTPase 
domain) backbone atoms E33 to G60 and T181 to D328 (this excludes the C-terminal α5 
helix and the N-terminal helix); and (2) the center of mass of the Gβ subunit, D38 to 
N340 (this excludes the N-terminal helix).  The vector between these two centers of mass 
was calculated for the starting structure (t=0 ns) and for each 1 ns frame of each 
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trajectory. The angle between the starting structure vector and that of each trajectory time 
point was projected into the x-y plane and measured.  
Results 
Mass Spectrometry Identification of CB2 and Gi Crosslinks 
 To identify contacts between CB2 and Gi, the CB2 receptor and Gi were 
crosslinked with either disuccinimidyl suberate (DSS) (Lys-Lys) or HgCl2 (Cys-Cys). 
Protein complexes were then purified by an M-2 anti-FLAG affinity column. Following 
SDS-PAGE separation, bands of the cross-linked CB2/Gi complexes were excised and 
subjected to enzymatic digestion with pepsin. We used the nonspecific enzyme pepsin to 
digest the crosslinked CB2-Gi protein complex, because there are very few trypsin 
digestion sites in the CB2 regions in which we were interested. The peptide mixtures 
resulting from in-gel digestions were analyzed by LC-MS/MS mass spectrometry. Data 
analysis was performed with the aid of the on-line server MS3D (24). The MS/MS 
spectrum of each candidate peptide was then manually checked to see whether it is a 
validated CB2-G protein crosslinked peptide. Several important guidelines were used for 
identification of crosslinked peptide, including: (1) The main MS/MS peaks should match 
fragment ions; (2) Fragment ions from each of the two peptides that are crosslinked 
should be found; (3) Fragments that contain both peptides and linker should be found. 
 The ESI-MS/MS spectrum of crosslinked peptides between CB2 and Gi are 
shown in Figure 1 (A-C). The fragment ions corresponding to two crosslinked peptides 
are designated with either the α (peptide from CB2) or β (peptide from Gi) subscript to 
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indicate the peptide of origin.  In Figure 1A, the spectrum can be assigned to two 
peptides: peptide α from CB2 with a sequence of RYLCLRY and peptide β from Gi with 
a sequence of KNNLKDCGL. The only cysteines in these two sequences that would have 
been available for crosslinking are Cys-134 in CB2 and Cys-351 in Gi. Close inspection 
revealed the presence of three ions that originate from cleavage reactions involving both 
peptide chains, i.e., b7 /y6, a4 /b7, and b4 /b7. 
 In Figure 1B, the spectrum can be assigned to two peptides: peptide α from CB2 
with a sequence of LAKTL and peptide β from Gi with a sequence of LKDCG. The 
only lysines in these two sequences that would have been available for crosslinking are 
Lys-245 in CB2 and Lys-349 in Gi. The spectrum was closely examined for the possible 
presence of fragment ions originating from cleavages involving both peptide chains. 
There are five ions that originate from cleavage reactions involving both peptide chains. 
For example, y3α/b3β demonstrates clearly the crosslink between Lys-245 in CB2 and 
Lys-349 in Gi. 
 In Figure 1C, the spectrum can be assigned to two peptides: peptide α from CB2 
with a sequence of HVLWKA and peptide β from Gi with a sequence of KDTKE. There 
are eight ions that originate from cleavage reactions involving both peptide chains. 
Among these, y2α-H2O/y2β demonstrates directly the crosslink between Lys-215 in CB2 
and Lys-317 in Gi. 
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Figure 1. (A) The ESI-MS/MS 
spectrum of a crosslinked peptide 
between CB2 and Gαi is presented 
here. The [M+2H]2+ peak at m/z 
1095.105 (M = 2188.21) was 
selected as the precursor ion with a 
collision energy of 35 eV. The 
peptide α from CB2 and the peptide 
β from Gαi crosslinked between  
Cys-134 and Cys-351. 
 
 
 
 
 
Figure 1. (B) The ESI-MS/MS 
spectrum of a crosslinked peptide 
between CB2 and  Gαi  is presented 
here. The [M+2H]2+ peak at m/z 
609.30 (M = 1216.60) was selected 
as the precursor ion with a collision 
energy of 35 eV. The peptide α 
from CB2 and the peptide β from 
Gαi crosslinked between Lys-245 
and Lys-349. 
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Figure 1. (C) The ESI-MS/MS 
spectrum of a crosslinked peptide 
between CB2 and Gαi is presented 
here. The [M+2H]2+ peak at m/z 
755.89 (M = 2264.67) was selected 
as the precursor ion with a collision 
energy of 35 eV. The peptide α 
from CB2 and the peptide β from 
Gαi crosslinked between Lys-215 
and Lys-317. 
 
 
 
 
 
Figure 1. MS Spectrums of CB2 and Gαi Crosslinks 
 
 
Orientation of Gαi1β1γ2 Protein in the Initial CB2 R* / Gαi1β1γ2 Protein Dock 
 Our initial dock of CB2 R* with Gαi1β1γ2 protein (Figure 2) was based on the 
crystal structure of the β2 adrenergic receptor in complex with Gs protein (32). In this 
structure, the C terminal α5 helix of Gαs is inserted between TMH3, TMH5 and TMH6, 
pointing towards the TMH7/Hx8 “elbow” region. TMH5 is packed closely with the C 
terminal α5 helix. This orientation of Gαs places the N terminus of Gαs below TMH3 and 
TMH4, while the receptor IC2 loop fits in the region between the C terminus and N 
terminus of Gαs. 
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Figure 2. CB2 R* / Gαi1β1γ2 
Protein Complex 
The CB2 receptor is shown in 
orange bound to 2-AG (VdW green 
carbons and red oxygens). The Gαi1 
subunit of the Gαi1β1γ2 
heterotrimer, is in magenta, Gβ1 is 
in blue and Gγ2 is in cyan. The 
palmitic and myristic acids 
attached to Gαi1 are shown in VdW 
colored magenta.  The 
geranylgeranyl group attached to 
Gγ2 is shown in VdW and colored 
cyan. GDP is bound between the 
helical and ras-like domains of 
Gαi1.  Here, GDP is shown in VdW 
display with carbons, nitrogens and 
oxygens colored green, blue and 
red respectively.  
 
 
 
Cysteine Crosslink Between TMH3 and Gαi1 C-Terminal 5 helix 
 The Cα- Cα distance range for formation of a cysteine crosslink using HgCl2 is 7 
to 10 Å (44,45). The cysteine crosslink identified by LC/MS/MS analysis from the HgCl2 
(Cys-Cys) crosslinking study was found to be between C3.54 (134) and C351 on the Gαi1 
-5 helix (i-3 residue).  The Cα- Cα distance between these two residues in the initial 
CB2/Gαi1β1γ2 complex was found to be 10.6Å, which is just 0.6 Å outside the range for a 
cysteine crosslink formation using HgCl2. The Cα positions of the crosslinked residues 
(colored yellow) at t=0 ns in the context of the whole complex is shown in Figure 3A. 
Figure 3B presents a close-up view. 
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Lys-Lys Crosslinks  
 
 The spacer arm length, N-N distance reported for disuccinimidyl suberate (DSS) 
is 11.4 Å (46). L-lysine measures 6.4 Å from α carbon to nitrogen (47). This makes 24.2 
Å the maximum Cα- Cα distance for formation of a Lys-Lys crosslink.  The first lysine 
crosslink identified by LC/MS/MS analysis was between K6.35 (245) on TMH6 and 
K349 on the Gαi1 5 helix (i-5 residue on C terminal). In the initial CB2/Gαi1β1γ2 
complex, these residues were 17 Å apart (Cα- Cα), which is within the range for 
formation of the DSS (Lys-Lys) crosslink. In addition, the space between these two 
residues provides no steric obstruction to crosslink formation. The Cα position of the 
crosslinked residues (colored cyan) at t=0 ns in the context of the whole complex is 
shown in Figure 3A. Figure 3C presents a close-up view.  
 The initial Cα- Cα distance for the second Lys-Lys crosslink between K5.34 (215) 
on TMH5 and K317 in the α4β6 region of Gαi1 was 24.5Å. This distance is only 0.3 Å 
outside the range for the formation of these Lys-Lys crosslinks. However, it is not 
sterically possible to form this crosslink even if the distance was lower because the space 
between these two residues is blocked by the intracellular end of TMH6. This is 
illustrated in Figure 3C, where the intracellular extension of the TMH6 (shown in 
magenta) provides this steric obstruction (t=0 ns). In figure 3D the Cα positions of K5.64 
(215) and K317 are colored red. This suggests that during the dynamic interaction of the 
two proteins, this region may change conformation allowing these residues to be 
crosslinked. Our MD simulations of the CB2 R*/ Gαi1β1γ2 protein complex embedded in a 
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POPC bilayer test this hypothesis. Figure 4 illustrates the full system for Trajectory 1 
simulated over time, including the POPC bilayer (lipid acyl chains, cyan; phosphate 
atoms in phospholipid headgroup, open gold circles), the CB2 receptor (orange) and 
Gαi1β1γ2 protein (green) with the Gαi1 α5 helix shown in yellow.  
 
Figure 3. Crosslinked Residues 
on CB2 R* / Gαi1 Protein 
 (A) This figure shows the spatial 
location of the three crosslinks 
identified between CB2 R* and 
Gαi1 protein in the starting structure 
for MD.  
(B) The α-carbons of the two 
residues linked using HgCl2, C3.54 
(134) on CB2 and C351 on the Gαi1 
-5 helix (i-3 residue) are shown 
here in yellow. 
(C) Illustrated here is one pair of 
residues (shown in cyan) 
crosslinked with DSS, K6.35 (245) 
on CB2 TMH6 and K349 on the 
Gαi1 5 helix (i-5 residue on C 
terminal). 
(D) Illustrated here are the α-
carbons of residues crosslinked 
with DSS, K5.64 (215) on CB2 
TMH5 and K317 (shown in red) on 
the Gαi1 (green) 4β6 loop. The 
intracellular end of TMH6 that sterically obstructs this crosslink in the initial complex is 
colored magenta. 
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Figure 4. CB2 R* / Gαi1β1γ2 Protein Complex in Lipid Bilayer 
This figure illustrates the full system for Trajectory 1 simulated over time here including 
the POPC bilayer (fatty acid acyl chains, cyan; phosphate atoms in phospholipid 
headgroup, open gold circles), the CB2 receptor (orange) and Gαi1β1γ2 protein (green) 
with the Gαi1 α5 helix shown in yellow.  
 
Molecular Dynamics Simulations 
 Molecular dynamics (MD) calculations reported here used the results of 
crosslinking experiments to validate the receptor-G protein complex that emerged from 
our simulations.  Crosslinking information was not used as a constraint for these 
simulations. It is also important to note that because of pepsin digestion, it is impossible 
to know whether all three crosslinks occurred in a single CB2-Gαi complex, whether each 
crosslink was found in a different CB2-Gαi complex or any other permutation between 
these two extremes. In other words, we do not know in advance if all three distance 
constraints implied by the cross-linking are ever met simultaneously.  In the starting 
structure for the MD simulations, the Cys-Cys crosslink is just outside the range for 
crosslink formation. One of the Lys-Lys crosslinks is within range to form in the initial 
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CB2-Gi protein complex similar to β2-AR*/ Gαsβ1γ2 complex.  The second Lys-Lys 
crosslink, however, is not initially possible due to steric obstruction from the IC extension 
of TMH6. .  
 Results from our two independent 1 s long trajectories suggest that 
conformational changes occur in both CB2 and Gαi1β1γ2 during the first 300-400 ns of the 
trajectories, as these proteins optimize their interaction with each other: Gαi1β1γ2, re-
orients with respect to the receptor and uses a CB2 IC-2 loop interaction to register the 
two proteins into new orientations, whereas TMH5 and TMH6 on CB2 move outward, 
reorganizing the associated IC-3 loop.  These changes are discussed in detail below. 
Rotation of Gαi1β1γ2 Relative to CB2 
 Figure 5A illustrates the change about the z-axis in Gαi1β1γ2 orientation relative to 
CB2 that occurs within the first 300 ns in Trajectory 1. Here, the perspective is from the 
receptor interface toward the cytoplasm through the TMH bundle (the CB2 receptor is 
omitted from the view for clarity). A clockwise rotation of ~250 can be clearly seen by 
considering the change in position of the N-terminal helix of Gαi1 (Figure 5A, shown in 
cylinder display: purple cylinder (t=0 ns) versus green cylinder (t=300 ns)). A similar 
rotation occurs in Trajectory 2 within the first 400 ns (not shown). Figure 5B shows the 
evolution of the rotation angle for Trajectory 1 (black) and Trajectory 2 (blue).  The red 
and yellow lines in figure 5B represent the running averages.  It is clear here that the 
distances plateau at about 300ns for Trajectory 1 and 400ns for Trajectory 2.  Although 
the rotation angle for Trajectory 1 stabilizes to ~25, the rotation for Trajectory 2 is ~35. 
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Figure 5. Change in the Gαi1β1γ2 Protein Relative to CB2 Receptor 
(A) This figure illustrates for Trajectory 1 that a rotation of the entire Gαi1β1γ2 protein 
(t=0 ns, purple; t=300 ns, green) relative to CB2 occurs along the z-axis. Here the view is 
from the receptor interface toward the cytoplasm.   The CB2 TMH bundle has been turned 
off for clarity.  A clockwise rotation of ~250 can be clearly seen by considering the 
change in position of the N-terminal helix of Gαi1 (shown in cylinder display: purple 
cylinder (t=0 ns) versus green cylinder (t=300 ns).  
(B)  This graph shows the evolution of the rotation angle for Gαi1β1γ2 relative to the CB2 
TMH bundle over time in Trajectory 1 (black line) and Trajectory 2 (blue line). The red 
and yellow lines represent the running average over 100 ns for Trajectory 1 and 
Trajectory 2 respectively. 
 
Change in Gαi1 C-Terminal α5 Helix Tilt 
 Figure 6 illustrates that another important change in Gαi1β1γ2 orientation relative 
to CB2 occurred during the MD runs. Here the intracellular ends of TMH5-6-7 and Hx8 
are shown with TMH-1-2-3-4 omitted for clarity. The C-terminal α5 helix of Gαi1 is 
shown in cylinder display (Figure 6, green).  In Trajectory 1 (Figure 6A), the C-terminal 
α5 helix of Gαi1 changed from a tilt towards the TMH7-Hx8 elbow (as seen in the crystal 
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structure of the 2-AR(32)) to a tilt more aligned with the membrane normal, bringing 
the extreme C-terminus near the IC end of TMH6.  This change occurred over the first 
300 ns of the MD production run and was maintained through the rest of the trajectory 
(t=300 nst=1,000 ns). Results were similar for Trajectory 2 (Figure 6B) except that the 
change in orientation happened over the first 400 ns. In both trajectories, the α5 helix 
changes its orientation by pivoting about a point near the center of the α5 helix in a rigid 
body motion.  The helix does not also roll or undergo a face shift.  
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Figure 6. Change in the C-Terminal α5 Helix of Gαi1 
This figure illustrates an important change in Gαi1β1γ2 orientation relative to CB2 
occurred during the MD runs. Here the intracellular ends of TMH5-6-7 and Hx8 are 
shown in blue, cyan, orange and magenta respectively. TMH-1-2-3-4 omitted for clarity 
and the C-terminal α5 helix of Gαi1 is shown in green cylinder display.   
(A) In Trajectory 1, the C-terminal α5 helix of Gαi1 changed from a tilt towards the 
TMH7-Hx8 elbow (as seen in the crystal structure of the 2-AR (32)) to a tilt more 
aligned with the membrane normal, bringing the extreme C-terminus near the IC end of 
TMH6.  This change occurred over the first 300 ns of the MD production run and was 
maintained through the rest of the trajectory (t=300 nst=1,000 ns).  
(B) Results were similar for Trajectory 2 except that the change in orientation happened 
over the first 400 ns of the MD production run and was maintained through the rest of the 
trajectory (t=400 nst=1,000 ns). 
 
 
IC-2 /Gαi1β1γ2 “Registering” Interaction 
 The rotation of Gαi1β1γ2 about the z-axis (illustrated in Figure 5) promotes an 
interaction between the IC-2 loop of CB2 and a hydrophobic pocket on Gαi1 (see Figure 
7). This hydrophobic pocket is composed of residues immediately after the Gαi1 N-
terminus (V34), residues on the Gαi1 β1 and β2 sheets (L194 and F196), as well as 
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residues on the Gαi1 α5 helix (I344, I343, T340 and F336). In our initial CB2 R*/ Gαi1β1γ2 
dock (based on the β2-AR/ Gαsβ1γ2 crystal structure), the IC-2 loop of CB2 was located 
between the N-terminal helix and C-terminal helix of Gαi1, on top of the loop connecting 
the β2 and β3 sheets. Figure 7 (t=0 ns) illustrates the hydrophobic pocket and the 
orientation of the receptor IC-2 loop relative to this pocket at the beginning of each 
trajectory.  As the result of the rotation of Gαi1β1γ2 about the z-axis discussed previously 
(see Figure 5), an IC-2 loop residue, P139, establishes a hydrophobic interaction with the 
hydrophobic pocket residues on Gαi1 within the first 300 ns of the Trajectory 1 (Figure 
7A) and 400ns of Trajectory 2 (Figure 7B). Over both 1 s trajectories, P139 entered and 
exited the hydrophobic pocket several times, but the rotation of Gαi1β1γ2 about the y-axis 
ceased once this “registering” interaction was established around 300 ns for Trajectory 1 
and 400ns for Trajectory 2.  
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Figure 7. IC-2 Proline 139 Interaction with Gαi1β1γ2 Protein 
This figure shows the interaction between the CB2 IC-2 loop residue (P139, colored 
orange) and a hydrophobic pocket on Gαi1.  This hydrophobic pocket is composed of 
residue(s) immediately after the Gαi1 N-terminus (V34, colored purple), residue(s) on the 
Gαi1 β1, and β2 sheets (L194 and F196, colored purple), as well as residues on the Gαi1 
α5 helix (F336, T340, I343 and I344, colored green).  
(A) This shows the interaction of P139 with the hydrophobic pocket at selected time 
points over 1 s in Trajectory 1. The first interaction of P139 with the hydrophobic 
pocket occurred at t=300 ns.  
(B) This shows the interaction of P139 with the hydrophobic pocket at selected time 
points over 1 s in Trajectory 2. The first interaction with the hydrophobic pocket in 
Trajectory 2 occurred at t=400 ns. 
 
The interaction of P139 with the hydrophobic pocket can also be followed by considering 
the solvent accessible surface area (SASA) of P139 over the course of each trajectory or 
the interaction energy of P139 with the hydrophobic pocket over the course of the 
trajectory. At the start of the Trajectory 1, the SASA of P139 was 200 Å2 (t=0 ns), but 
decreased to 80 Å2 during the period between 250 ns and 300 ns (black line in Figure 8A) 
and for Trajectory 2, the SASA of P139 was 200 Å2 (t=0 ns), but decreased to 100 Å 
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during the period between 350 ns and 400 ns (blue line in Figure 8A). The interaction 
energy between P139 and the hydrophobic pocket was close to zero at the start of 
Trajectory 1, but dropped to -7 kcal/mol between 250 ns to 300 ns (black line Figure 8B).  
For Trajectory 2, the interaction energy dropped to -5 kcal/mol between 350 ns to 400 ns 
(blue line Figure 8B).  
 
 
 
Figure 8. Solvent Accessible Surface Area and Interaction Energy of Proline 139 
These plots (Trajectory 1, black; Trajectory 2, blue) show the change in the  
(A) Solvent accessible surface area and  
(B) Van der Waals interaction energy  
for the P139 (CB2 IC-2 loop) interaction with the Gαi1 hydrophobic pocket. The red and 
yellow lines represent the running average over 100 ns for Trajectory 1 and Trajectory 2 
respectively. Over the 1000 ns trajectory, P139 entered and exited the hydrophobic pocket 
several times, but the rotation of Gαi1β1γ2 about the z-axis ceased once this anchoring 
interaction was first established at 300 ns for Trajectory 1 and 400ns for Trajectory 2. (see 
Figure 7 for further detail). 
 
 
Shape of α5 Helix C-Terminal Portion  
 The crystal structure of Gαi1β1γ2 is missing the last ten residues of the Gαi1 α5 
helix. The three-dimensional structure of the transducin (Gt) α subunit C-terminal 
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undecapeptide Gαt 
340IKENLKDCGLF350 was determined by Kisselev et al. using 
transferred nuclear Overhauser effect spectroscopy while it was bound to photoexcited 
rhodopsin (PDB 1AQG) (27). Light activation of rhodopsin caused a dramatic shift from 
a disordered conformation of Gαt (340–350) to a binding motif with a helical turn 
followed by an open reverse turn centered at Gly-348, with a helix-terminating C capping 
motif of an αL type. We used this NMR structure to complete the missing C-terminus of 
Gαi1 in our initial model of the CB2 G protein complex. Figure 9A shows a comparison of 
the Gαt (340–350) NMR structure (cyan) with the corresponding last ten residues of Gαi1 
at t=400 ns in each simulation (Trajectory 1, purple; Trajectory 2 green). It is clear that 
the in both the trajectories the two segments have very similar shapes. We calculated the 
RMSD of the Cα’s of the last ten residues of Gαi1 in our simulations versus the NMR 
structure. The RMSD plot in Figure 9B shows that this region of the C-terminus of Gαi1 
undergoes changes during the period (t=0 ns  t=300 ns) for Trajectory 1  and (t=0 ns  
t=400 ns) for Trajectory 2  when the tilt of the Gαi1 5 helix is changing, but the RMSD 
reaches a stable value by 300 ns  for Trajectory 1 and 400 ns for Trajectory 2 and remains 
low thereafter. 
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Figure 9. Shape of the C-Terminal α5 Helix of Gαi 
(A) This figure shows a comparison of the Gαt (340–350) NMR structure (27) (cyan) 
with the corresponding last ten residues of Gαi1 at t=400 ns in Trajectory 1 (purple) and 
Trajectory 2 (green). It is clear that the two segments from both the trajectories have very 
similar shapes.  
(B) The RMSD plot versus simulation time shows that I344 to F354 region of the C-
terminus of Gαi1 undergoes changes during the period (t=0 ns  t=300 ns for Trajectory 
1 (black line) and t=0 ns  t=400 ns for Trajectory 2 (blue line)), but the RMSD reaches 
a stable value by 300 ns for Trajectory 1 and 400ns for Trajectory 2 and remains low 
thereafter. The red and yellow lines represent the running average over 100 ns for 
Trajectory 1 and Trajectory 2 respectively. 
 
 
Why Does the 5 Helix Change Its Tilt? 
 There are two differences between the CB2/ Gαi1β1γ2 and β2-AR/Gαsβ1γ2 
complexes that may contribute to the change in tilt of the 5 Helix.  These are Gα 
sequence differences and GPCR sequence differences. 
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1. Sequence Differences- α5 Helix 
 The reorientation of the Gαi1 α5 helix illustrated in Figures 5 may be attributable 
in part to sequence differences between Gαs and Gαi. The sequences of the last ten 
residues of the various isoforms of Gα (Gαi1, Gαi2, Gαo, Gαt, Gαs, Gαq etc.) have high 
homology; however, there is an important difference at the i-4 position.  For the Gαi 
proteins, this position is occupied by a negatively charged residue (D in Gαi1 and Gαi2; E 
in Gαi3). For Gαs, however, this position is an uncharged residue (Q390 (i-4)).  Figure 10 
illustrates the difference in the interaction of the extreme C-terminus of Gαi1 with the 
receptor that occurs partly as a consequence of this sequence difference.  In the β2-AR 
(see Figure 10A), R3.50 has an aromatic stacking interaction with Y391 (i-3) on the Gαs 
5 helix. Although our initial dock of Gαi with CB2 R* mimicked this (see Figure 10B), 
during the initial 300-400 ns of the trajectories, the 5 helix changed its tilt angle to be 
more aligned with the membrane normal.  This tilt change allows CB2 R3.50 to now 
interact with D350 (i-4) on the Gαi 5 helix (see Figure 10C), while CB2 R3.55 interacts 
with L353 (i-1) on the Gαi 5 helix.  This latter interaction is a Van der Waals interaction. 
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Figure 10. TMH3 and C-Terminal α5 Helix Interaction 
This figure illustrates the interaction between receptor residues at the intracellular end of 
TMH3 with the three (i-1, i-3, i-4) residues of the C-terminal α5 helix of Gα.  
(A) This figure shows that R3.50 of the β2-AR receptor interacts with Y391 (i-3) on Gαs 
(32). (B) This figure shows that in the initial CB2/Gαi1β1γ2 complex, R3.50 interacts with 
C351 (i-3) on Gαi1 and R3.55 interacts with L353 (i-1). Here, the tilt of the α5 helix is 
very similar to that of Gαs in part A.  
(C) However, after 295 ns in Trajectory 1, the tilt angle of the Gαi1 α5 helix has changed 
permitting CB2 R3.50 to form a salt bridge with D350 (i-4) on Gαi1, while the 
hydrocarbon portion of R3.55 has a VdW interaction with L353 (i-1).  Note here that in 
order to establish these interactions; the α5 helix changes its tilt angle to be more aligned 
with the membrane normal. 
 
2. Sequence Differences-TMH5-TMH6 Movement 
 To accommodate the re-orientation of the Gαi1 α5 helix and the rotation of 
Gαi1β1γ2, CB2 undergoes an outward movement of TMH5-TMH6 and the associated IC-3 
loop moves away from the CB2 TMH bundle.  This is illustrated in Figure 11 for 
Trajectory 1.  This is facilitated by the fact that both TMH5 and TMH6 have hinge points 
that allow these helices to move away from the TMH bundle when CB2 is activated (17). 
TMH5 hinges at G5.53 (204), whereas the hinge point for TMH6 is at G6.38 (248).  
Figure 12 shows that the position of the CB2 IC-3 loop relative to the Gαi1 α4β6 loop 
changes before 300 ns in the Trajectory 1. Here the G protein has clearly undergone a 
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rotation that places the α4β6 loop of Gαi1 near the IC-3 loop of CB2. This movement also 
removes the steric obstruction to the formation of the Lys-Lys crosslink between K5.34 
(215) on TMH5 and K317 in the α4β6 region of Gαi1 that existed at the outset of the 
simulation (see Figure 3D).   Similar results were obtained with Trajectory 2. 
 
Figure 11. Outward Movement of 
TMH5 - TMH6 
The CB2 (shown partially) structure 
at t=0 ns is colored gray here, while 
the CB2  structure at t=300 ns is 
colored orange for Trajectory 1 
from the TMH6-7 perspective.  
Intracellular extension of TMH5-
TMH6 including IC3 at t=0 ns is in 
grey and magenta while same at 
t=300 ns is colored green. 
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Figure 12. Movement of Intracellular Loop 3 (IC3) 
This figure shows that the position of the CB2 IC-3 loop (magenta) relative to the Gαi1 
α4β6 loop (green) at  
(A) t=0ns  
(B) t=251ns  
in the Trajectory 1. Here the G protein has clearly undergone a rotation that places the 
α4β6 loop of Gαi1 near the IC-3 loop of CB2. This movement also removes the steric 
obstruction to the formation of the Lys-Lys crosslink between K5.34 (215) on TMH5 and 
K317 in the α4β6 region of Gαi1 that existed at the outset of the simulation (see Figure 
3D). Similar results were obtained with Trajectory 2 (not shown). 
 
 
Crosslink Correlations: Cysteine Crosslink between TMH3 and C-Terminal Gαi1 α5 
Helix 
 In order to test if experimentally obtained crosslinks were possible in Trajectories 
1 and 2, we considered Cα- Cα distances for each pair of linked residues.  We compared 
these distances to the range of Cα- Cα distances over which the crosslinking has been 
shown to form. In some trajectories this distance was below the cut-off distance for the 
entire trajectory.  In others, there were only regions of the trajectory that were below the 
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cut-off. We begin here by discussing each of the crosslinks individually.  At the end of 
this section, we assess in what percentage of the trajectories is the Cα- Cα distance below 
the cut-off at the same time.  Figure 13A shows a plot of the Cα- Cα distance between 
C3.54 (134) on CB2 and C351 on the Gαi1 5 helix (i-3 residue on C terminal) for both 
trajectories. This plot has the distance range for cysteine crosslink formation indicated by 
the green lines. This distance was 10.6 Å in the starting structure, which was just 0.6 Å 
outside the crosslink range.  The distance does decrease into the range of 7 - 10 Å, for 
multiple times in both trajectories.  As a result, we conclude that our MD simulations 
suggest that the formation of a Cys-Cys crosslink is possible. 
Crosslink between TMH6 and C-Terminal 5 Helix of Gαi1  
 Figure 13B shows a plot of the Cα- Cα distance for the Lys-Lys crosslink between 
K6.35 (245) on CB2 and K349 on the Gαi1 5 helix (i-5 residue on C terminal) for both 
the trajectories.  The green line at 24.2Å indicates the distance below which a crosslink 
would be possible. The plot shows that this distance remained around 15 Å during the 
entire 1 µs MD simulation for both the trajectories.  In addition, there were no steric 
obstructions of this interaction present at any time in either trajectory. Therefore, we 
conclude that our MD simulations suggest that the formation of this Lys-Lys crosslink is 
possible. 
  
34 
 
(A) The Cα- Cα distance between 
C3.54 (134) and C351 on the Gαi1 
5 helix (i-3 residue on C terminal) 
is shown here. The green lines at 7 
Å and 10 Å correspond to the 
distance range for crosslink 
formation between two cysteines 
using HgCl2. 
 
 
 
 
(B) The Cα- Cα distance between 
K6.35 (245) and K349 on the Gαi1 
5 helix (i-5 residue on C terminal) 
is shown here. The green line at 
24.2 Å is the maximum Cα 
distance to form a crosslink 
formation between two lysines 
using DSS.  
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(C) The Cα- Cα distance between 
K5.64 (215) and K317 on the Gαi1 
4β6 loop is shown here. The 
green line at 24.2 Å is the 
maximum Cα distance to form a 
crosslink formation between two 
lysines using DSS.  The hatched 
area before 200 ns represents that 
part of trajectory during for which 
the intracellular end of TMH6 
sterically obstructs this crosslink.  
This corresponds to the section of 
TMH6 colored magenta in Figure 
3D.  
 
Figure 13. Distances Between the Crosslinked Residue Pairs 
A plot of Cα- Cα distance as a function of simulation time is shown here for the three 
crosslinks reported here. Trajectory 1 is shown in black and Trajectory 2 is blue. The red 
and yellow lines represent the running average over 100 ns for Trajectory 1 and 
Trajectory 2 respectively. 
 
 
Crosslink between TMH5 and the Gαi1 α4β6 Loop 
 We have indicated above that one consequence of the Gαi1β1γ2 rotation relative to 
CB2 is that TMH5-IC3-TMH6 moves away from the TMH bundle at the IC side in the 
first 300 ns for Trajectory 1 and 400 ns for Trajectory 2.  Prior to this movement, it is 
structurally impossible to crosslink K5.34 (215) on TMH5 and K317 in the α4β6 region 
of Gαi1 even though the Cα- Cα distance between these residues is below the 24.2Å cutoff 
for crosslink formation. Figure 13C shows a plot of the Cα - Cα distance for this Lys-Lys 
crosslink for both trajectories. That section of the simulation for which the crosslink is 
structurally not possible is indicated by the hashed region.  For Trajectory 1 (black line in 
figure 13C), once the structural interference is removed as TMH5-IC3-TMH6 moves 
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away from the bundle, the crosslink is possible at all other time points.  Trajectory 2 (blue 
line in figure 13C) does have one region that goes above the allowed distance after the 
steric obstruction is cleared (200 - 375 ns).  After this region, the Cα- Cα distance for 
Trajectory 2 remains below the cut-off. Therefore, our MD simulations suggest that the 
formation of this Lys-Lys crosslink is also possible. 
 Finally, we assessed at 1 ns intervals for both trajectories, those times for which 
all three sets of Cα- Cα distances were below the cut-off (and therefore possible) at the 
same time. We found that in Trajectory 1, this percentage was 60.8%, while for 
Trajectory 2, this percentage was 33.4%. 
Discussion 
 High-resolution X-ray structures have been obtained for multiple class A 
(“rhodopsin-like”) GPCRs (3-6,48-56), various G protein heterotrimers (Gαβγ) 
(26,57,58)  and isolated Gα subunits in different functional states (59-61). Combined with 
biochemical and biophysical data, these structures reveal a surface on Gα that is predicted 
to face the intracellular side of GPCRs. Information about the nature of this interface has 
been obtained via x-ray crystallography and chemical cross-linking studies.  At present, 
there is only one crystal structure of a GPCR–G protein complex available (32), which 
shows the interaction of the β2 adrenoreceptor (β2-AR) with Gs protein after GDP has 
dissociated from the Gα subunit. This structure represents an empty state that exists 
between the GDP bound and GTP bound G protein, artificially stabilized by a nanobody, 
insertion of which was necessary for crystallization (32).  
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 Chemical crosslinking studies of protein-protein interactions can identify pairs of 
residues that come close enough to each other to form a respective crosslink. The 
identification of multiple crosslink sites can provide information about the relative 
orientation of the two interacting proteins.  
 In this paper, a comprehensive GPCR–Gi, protein chemical cross-linking 
strategy was applied with the goal of ascertaining the orientation of the CB2 receptor 
relative to Gαi1.  These experiments revealed three crosslinks:  (1) a  cysteine crosslink 
between TMH3 residue C3.54 (134) and C351 on the Gαi1 5 helix (i-3 residue); (2) a 
lysine crosslink between TMH6 residue K6.35 (245) and K349 on the Gαi1 5 helix (i-5 
residue); and (3) a lysine crosslink between TMH5 residue K5.64 (215) and K317 on the 
Gαi1 α4β6 loop. An examination of the initial complex we constructed to mimic the β2-
AR*/ Gαsβ1γ2  x-ray crystal structure (32) revealed that one of these crosslinks (K6.35 
(245) to K349) is possible in the initial complex.  A second crosslink (C3.54 (134) to 
C351) is only 0.6 Å above the Cα - Cα distance limit for crosslinking in the initial 
complex. But the third crosslink was sterically impossible in the initial complex.  This 
suggested that  either  the orientation of the G protein with respect to a GPCR varies 
depending on the receptor and G protein to be complexed or that the orientation of 
Gαsβ1γ2 with respect to the β2-AR* in the crystal structure changes after GDP leaves the 
Gαs subunit, as has occurred in the β2-AR*/ Gαsβ1γ2 crystal structure. 
 To understand the origins of the experimental crosslinks between CB2 and Gαi 
identified in this paper, we undertook microsecond timescale molecular dynamics 
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simulations of the CB2 R*/ Gαi1β1γ2 complex in a POPC bilayer. We show here that when 
two MD runs of the CB2 R*/ Gαi1β1γ2 complex in lipid are initiated using the same G 
protein orientation (including the angle of the Gαi1 5 helix) as seen in the β2-AR*/ 
Gαsβ1γ2 crystal structure, rearrangements ensue fairly quickly in each.  There is a gross 
clockwise rotation of the entire G protein underneath CB2 R* during the first 300 ns 
(Trajectory 1) or 400 ns (Trajectory 2) of the production runs. This rotation ceases once 
an interaction is established between the IC-2 loop residue, P139 and a hydrophobic 
pocket on Gαi1 formed by residues V34, L194, F196, F336, T340, I343 and I344. 
A change in the tilt of the Gαi1 5 helix also occurs early in the trajectories facilitated by 
the outward movement of TMH6 and TMH5 at their IC ends.  The change in tilt allows 
R3.50 on CB2 to form a salt bridge with D350 (i-4) on the Gαi1 5 helix.   
Importance of the Gαi1 5 Helix and the Change in Its Tilt Angle 
In the present crosslinking study, a cysteine crosslink was formed between TMH3 
residue C3.54 (134) and C351 on the Gαi1 5 helix (i-3 residue).  The extreme C 
terminus was one of the first regions within Gα identified as being critical to receptor-
promoted activation. Hamm and co-workers (62) first demonstrated that synthetic 
peptides corresponding to the C terminus of Gαt could block rhodopsin promoted 
activation, suggesting that the C terminus of Gα is a critical receptor-binding site. 
Alanine-scanning experiments confirmed that the C terminus/α5 helix were essential for 
rhodopsin-promoted activation of Gαt (63).  In many early G protein crystal structures, 
the extreme C-terminus of Gα was unresolved. The first three-dimensional structure of 
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the transducin (Gt) α subunit C-terminal undecapeptide Gαt 
340IKENLKDCGLF350 bound 
to photoexicted rhodopsin registered in the Protein Data Bank was determined by using 
transferred nuclear Overhauser effect spectroscopy (27). Light activation of rhodopsin 
caused a dramatic shift from a disordered conformation of Gαt (340–350) to a binding 
motif with a helical turn followed by an open reverse turn centered at G348, with a helix-
terminating C capping motif of an αL type.  Docking of the NMR structure to the GDP-
bound x-ray structure of Gt reveals that photoexcited rhodopsin promotes the formation 
of a continuous helix over residues 325–346 terminated by the C-terminal helical cap 
with a unique cluster of crucial hydrophobic side chains. Subsequently, this C-terminal 
region has been resolved in three GPCR crystal structures: (1) the bovine Opsin*–Gα- C 
terminal peptide complex (64); (2) Meta II rhodopsin in complex with an 11-amino-acid 
C-terminal fragment derived from Gα (two residues mutated) (65); and (3) the β2-AR*/ 
Gαsβ1γ2  complex (32). In each of these structures, the shape of the extreme C-terminus is 
quite similar to the original NMR structure.  In work presented here, this NMR structure 
was used to complete the Gαi1 structure that was docked in CB2 R*.  The RMSD plot in 
Figure 9B shows that the shape of the last 10 residues in the C-terminal region has a low 
RMSD after the first 300 ns of production simulation for Trajectory 1 and 400 ns for 
Trajectory 2 when compared with the NMR structure. 
 We also report here that the insertion angle of the Gαi1 5 helix changed from its 
starting angle (which mimicked the β2-AR*/ Gαsβ1γ2 complex (32)).  Two reasons for 
this change are the position of the IC end of TMH5 in CB2 R* and a key sequence 
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difference between Gαi and Gαs at the i-3 position on the Gαi 5 helix.  One striking 
difference between the β2-AR and CB2 sequences is that the β2-AR has the highly 
conserved P5.50, while CB2 lacks this proline in TMH5 (L5.50 in CB2).  In the β2-AR*/ 
Gαsβ1γ2 complex (32)), TMH6 has moved away from the TMH bundle and broken the 
ionic lock (R3.50/E6.30), thus exemplifying an activated GPCR.  The proline kink region 
of TMH5 flexes, but moves TMH5 towards the TMH bundle interior.  When the 5 helix 
of Gαs inserts in this activated structure, it must insert in an opening formed by TMH6’s 
outward movement.  This region extends over to the elbow region of TMH7-Hx8. In the 
case of CB2, the C-terminal 5 helix of Gαi1 can insert into a wider opening, one formed 
by the TMH5 and TMH6 outward movement.  This in turn allows the angle of insertion 
to change in CB2.     
 R3.50 has been shown to be crucial for CB2 signal transduction. Feng and Song 
reported no stimulation of agonist induced [35S]GTPS binding for the R3.50A mutant in 
CB2 (66).  We show here that the change in the tilt angle of the 5 helix also permits 
formation of a salt bridge between R3.50 on CB2 and D350 (i-4) on the Gαi1 5 helix. 
D350 (i-4) occupies a position in the C-terminus of Gαi that has an important divergence 
from Gαs. For the Gαi‘s, this position is occupied by a negatively charged residue (D in 
Gαi1 and Gαi2; E in Gαi3). For Gαs, however, this position is an uncharged residue (Q390 
(i-4)).  Figure 10 illustrates the difference in the interaction of the extreme C-terminus of 
Gαi1 with the receptor that occurs partly as a consequence of this sequence difference.  In 
the β2-AR (see Figure 10A), R3.50 has an aromatic stacking interaction with Y391 (i-3) 
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on the Gαs 5 helix. Although our initial dock of Gαi with CB2 R* mimicked this (see 
Figure 10B), after 295 ns in Trajectory 1, the tilt of the 5 helix has changed such that 
Gαi1 moves towards TMH5 – TMH6, allowing R3.50 to now interact with D350 (i-4) 
(see Figure 10C), while the hydrophobic part of R3.55 interacts with L353 (i-1).  A 
similar change occurred in Trajectory 2. 
Second Intracellular Loop Interaction with Gα Protein 
 Interactions between GPCR IC-2 loops and G protein have been shown to be 
critical in GPCR/G protein coupling for numerous receptors. The IC-2 loop of the 
muscarinic M3 receptor has been shown to interact with the N terminal region of Gαq 
protein (67). IC-2 interactions also have been shown to be critical for coupling in the 
follicle-stimulating hormone receptor (FSH) with Gαs (68). In the β2-AR*/ Gαsβ1γ2 
crystal structure, IC-2 loop residue, F139, inserts into an aromatic/hydrophobic pocket on 
Gαs comprised of H41, V217, F129, F376, R380 and I383 on the Gαs C terminal region 
and Gαs, β2 and β3 sheets (see Figure 4c in ref (32)).  The importance of this interaction 
is underscored by mutagenesis studies which demonstrate that a β2-AR F139A mutation 
significantly impairs β2-AR coupling to Gαs (69).  We show here that Gαi1β1γ2 rotation 
about the z-axis ceased once the IC-2 loop residue, P139 establishes a hydrophobic 
interaction with the hydrophobic pocket residues on Gαi1 (Figures 6 and 7). The two 
proteins appear to be in “register” once this interaction occurs.  Consistent with this idea, 
no further Gαi1β1γ2 rotation occurs in either trajectory.  In support of the importance of 
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this interaction, Zheng and colleagues have reported that a P139A mutation in CB2 results 
in the loss of coupling with Gαi (70).  
Third Intracellular Loop Interaction with the α4β6 Region of Gα 
 Our chemical cross-linking strategy led to a DSS (Lys-Lys) crosslink between the 
TMH5 residue K5.64 (215) and K317 on the Gαi1 α4β6 loop. In the MD simulations 
reported here, this crosslink becomes possible only after Gαi1β1γ2 rotation under CB2 (see 
Figures 4, 5 and 11, 12). The importance of α4/β6 loop residues to GPCR/ G protein 
complex formation has been shown for multiple GPCRs.  Slessareva et al. have shown 
that the Gαi1 α4 helix- α4/β6 loop are involved in 5-HT1a, 5-HT1b and muscarinic M2 
receptor interactions (71). For the rhodopsin – transducin (Gαt) complex, residues in the 
Gαt α4β6 loop (R310 to K313) were shown to crosslink with residues in the IC-3 loop of 
rhodopsin using a photoactivatable reagent, N-[(2-pyridyldithio)-ethyl], 4-azido 
salicylamide (72).  For the rat M3 muscarinic acetylcholine receptor (M3R) – Gαq 
complex system, a crosslink has been reported between a D321C mutation on α4β6 loop 
of Gαq and a K7.58(548)C mutation on M3R.  Here the crosslinking agent was a short bi-
functional, irreversible chemical crosslinker bis-maleimisoethane (BMOE) (67).  
Conclusions 
 The result of this study is a CB2 R*/ Gαi1β1γ2 complex in which the proteins are in 
the correct register as indicated by chemical crosslinking studies. The next stage of this 
project will be the study of the changes that complex formation with CB2 R* induces in 
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Gαi1β1γ2.  Our ultimate goal will be the activated state of Gαi1β1γ2 in which GDP has been 
released. 
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CHAPTER II 
 
ROLE OF THE INTRACELLULAR LOOPS OF THE CANNABINOID CB2 
RECEPTOR IN THE ACTIVATION OF THE Gi PROTEIN 
 
 
Jagjeet Singh, Diane L. Lynch, Alan Grossfield, Dow P. Hurst, Michael C. Pitman and 
Patricia H. Reggio (To be published) 
 
 
Abstract 
 Previously, we used molecular dynamics simulations to study the activation of the 
cannabinoid CB2 receptor by its endogenous ligand, 2-arachidonoylglycerol (2-AG) via 
the lipid bilayer (17). We then reported the formation of the CB2 / Gαi1β1γ2 complex using 
our activated CB2 receptor model (73). In the next step of our study of the G-protein 
signaling cascade, we are studying the activation of the Gαi1 protein catalyzed by an 
activated CB2 receptor that leads to guanosine di phosphate (GDP) release (32,74,75). 
Here we report the relationship between specific receptor interactions with the Gαi1 
protein and the resultant progression of GDP hydration. We propose that such hydration 
is likely required for GDP release from Gα proteins. 
  Results from our 5µs MD simulations suggest that intracellular loop interactions 
contribute to the hydration of GDP, with the larger contribution from IC2 interaction, 
when P139 (IC2 loop of CB2) interacts with a hydrophobic pocket on Gαi1 (V34, L194, 
F196, F336, T340, I343 and I344) and a lesser contribution from the IC3 interaction,  
when R229 (IC3 loop of CB2) reaches to the end of the α4 helix to E297 and 
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E298. IC1 interactions (R66 on CB2 interaction with E28 on N terminal helix of Gαi1 
protein) with Gαi1 protein does not correlate with any increase in the GDP hydration. 
Taken together these findings suggest that IC2 and IC3 loops of CB2 interact with ras-like 
( GTPase) domain on the Gαi1 protein, resulting in an increase in GDP hydration.  
Introduction 
 The cannabinoid CB2 receptor is encoded by the CNR2 gene and is mainly 
expressed in T cells of the immune system (13). It has been also shown to be weekly 
expressed in the gastrointestinal system (14,15).  CB2 has also been reported to play an 
important role in central immune responses during neuropathic pain in mice (16). CB2 
belongs to Class A of the GPCRs and has been shown experimentally to couple only to 
Gαi inhibitory protein (18-20).   
 G protein coupled receptors (GPCRs) catalyze the activation of G-proteins by the 
releasing tightly bound guanosine diphosphate (GDP). GDP is held in the unactivated G-
protein between the ras-like (GTPase) and helical domains of the Gα protein. However 
the molecular mechanism by which this happens is not completely understood (21,76,77). 
Earlier studies have shown the importance of the Gα C-terminus and the α4-β6 loop of 
Gα (63,71,72) in receptor coupling. F139A mutagenesis studies of the β2-AR/Gs system 
have suggested that receptor IC-2 loop interaction with G-protein is critical (69). The 
only crystal structure of a GPCR/G-protein complex (β2-AR/Gs) clearly shows the 
interaction between F139 and a hydrophobic pocket in the ras-like domain of Gs (32). 
Receptor IC-3 loop involvement with the α4 helix (78,79) and the α4-β6 loop (71,72) of 
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the G-protein has also been shown important for G-protein activation. Taken together, the 
literature suggests the involvement of various regions on GPCRs with Gα protein regions 
to be important for G-protein activation but the molecular mechanism by which such 
dynamic interactions  in the complex lead to activation is also still unclear (21). 
  In the work reported here, we studied the role of CB2 intracellular regions in Gαi 
protein activation by using microsecond-long molecular dynamics simulations. We tested 
the hypothesis that GDP release upon activation requires the hydration of GDP. Results 
from our 5 µs MD simulations suggest that intracellular loop interactions do contribute to 
the hydration of GDP, with the larger contribution from IC-2 loop interaction and a lesser 
contribution from IC-3 loop interaction. In contrast, IC-1 loop interactions with Gαi1 
protein does not correlate with any increase in GDP hydration.  
Methods  
CB2 Receptor Model  
 The CB2 R* model used in this study was taken from our previously published 
microsecond-long simulation of the activation of the CB2 receptor by the endogenous 
ligand, 2-AG, via the lipid bilayer (17).  
G-Protein Modeling 
 For the current study, the crystal structure of Gαi1β1γ2 (26) was used to dock with 
CB2 R*. Missing parts of the Gαi1β1γ2 protein were completed as described in Chapter I.  
Briefly, to complete the missing extreme Gαi1 C-terminus, the NMR structure of Gαt was 
used (27) and the missing C-terminus of Gγ2 was built using the NMR structure of Gγ1 
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(28). Lipidation sites (Palmitic acid, Myristic acid) were attached to the N-terminus of 
Gαi1 at Cys3 (29) and Gly2 respectively (30) and a geranylgeranyl group was attached to 
Cys 68 in the Gγ2 C-terminus (31).   
CB2/Gi-Protein Complex 
 Our initial CB2 R* / Gαi1β1γ2 complex was based on the β2-AR / Gαsβ1γ2 complex 
crystal structure (32) as described in Chapter I. 
Construction of CB2/Gαi1β1γ2 Complex in POPC Bilayer 
 The CB2 R*/G protein complex was placed in the simulation cell size of 130.0Å x 
130.0Å x 170.6 Å as described in the Chapter I. The CB2/Gαi1β1γ2  protein complex was 
centered at the middle of the POPC lipid bilayer using scripts derived from CHARMM-
GUI (33). The CHARMM22 protein force field with CMAP corrections (35,80) and the 
CHARMM 36 lipid force field (36) were used in this study. Parameters for GDP  and 
lipidation sites were obtained as described in Chapter I (73).  
Molecular Dynamics Simulations 
 To relieve poor initial contacts, minimization and equilibration was performed 
using CHARMM (38), and NAMD (39) as previously published (73) For all production 
runs, NAMD (39) was used. Long range electrostatics were included using PME (40) 
(see Chapter I for details). Production dynamics was performed on the BSBC cluster at 
UNC Greensboro (http://bsbc.uncg.edu/index.html) and a Blue Gene supercomputer (41) 
located at the Thomas J. Watson Research Center, Yorktown Heights, New York. Results 
from the 5 µs long trajectory are reported here. The trajectory analysis was performed 
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using visual molecular dynamics (42) and the Lightweight Object-Oriented Structure 
library (LOOS) (43). 
Results 
CB2 R* / Gαi1 Protein Complex 
 The CB2 intracellular (IC) loops that directly interact with the Gαi1 ras-like 
domain were in close proximity of the Gαi1 ras-like domain in our initial CB2 R* / Gαi1 
protein complex (Figure 14). The Gαi1 C terminal α5 helix was pointing towards the CB2 
TMH7/Hx8 “elbow” region. The IC-3 loop was close to the Gαi1 α4β6 loop and α4 helix. 
The IC-2 loop was above the region between the Gαi1 N-terminal helix and the Gαi1 C 
terminal α5 helix. The IC-1 loop was away from the Gαi1 N terminal helix (Figure 14).  
 
Figure 14. The Orientation of 
CB2 Intracellular Loops Relative 
to Gαi Protein 
This figure shows the Gαi protein 
underneath the CB2 receptor. Here 
the CB2 receptor is shown in 
orange. The Gαi1 ras-like and 
helical domains are shown in 
purple and green respectively. The 
GDP bound between the Gαi1 
helical and ras-like domains is 
represented in VdW display with 
carbons, nitrogens and oxygens 
colored green, blue and red 
respectively. The CB2 IC loops are 
colored green, blue and cyan for 
IC-1, IC-2 and IC-3 respectively.  
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During our 5 μs long MD simulation of the CB2 / Gαi1 protein complex, the intracellular 
loops of the activated CB2 receptor developed interactions with various parts of the ras-
like domain of the Gαi1 protein. These interactions are discussed in detail below. 
IC-1 Loop Interactions with the Gαi1 N-terminal Helix 
 An electrostatic interaction between the CB2 IC-1 loop residue R66 and E28 on 
the Gαi1 N-terminal helix was observed (Figure 15A). This interaction started between 
600 ns to 750 ns for a short time, but between 1000 ns to 2800 ns these residues 
interacted with each other for a longer period. Then after losing their interaction for 
almost a microsecond, R66 and E28 regain their interaction from3900 ns until the end of 
the trajectory (Figure 15B).  
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Figure 15. CB2 IC-1 Loop Interactions with the Gαi1 N-terminal Helix 
(A) Figure 15A shows the interaction between R66 on the CB2 IC-1 loop with E28 on the 
Gαi1 N-terminal helix at t=2058 ns.  
(B) The black line in this figure represents the N-O distance between R66 on the CB2 IC-
1 loop and E28 on the Gαi1 N-terminal helix. The green line at 4.0 Å represents the 
maximum accessible distance between N and O (81). The red line represents the running 
average over a 100 ns frame.  
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IC-2 Loop Interaction with Gαi Protein 
 A hydrophobic interaction between Proline 139 on the IC-2 loop of CB2 and a 
hydrophobic pocket on Gαi1 protein was observed. This pocket includes residues from the 
Gαi1 N-terminus (V34), β1 and β2 sheets (L194 and F196), and α5 helix (I344, I343, 
T340 and F336). This interaction was not present in our initial CB2 R*/ Gαi1β1γ2 dock 
(based on the β2-AR/ Gαsβ1γ2 crystal structure), but developed over the trajectory (Figure 
16).  
 
 
 
Figure 16. CB2 IC-2 Loop /Gαi1β1γ2 Interaction 
This figure shows the interaction between the CB2 IC-2 loop residue (P139, colored 
orange) and a hydrophobic pocket on Gαi1.  This hydrophobic pocket is composed of 
residue(s) immediately after the Gαi1 N-terminus (V34, colored blue), residue(s) on the 
Gαi1 β1, and β2 sheets (L194 and F196, colored blue), as well as residues on the Gαi1 α5 
helix (F336, T340, I343 and I344, colored green).  
(A) This shows the starting structure (t=0ns) in which P139 (orange) is in the proximity 
of the Gαi1 hydrophobic pocket, but not pointing towards it.   
(B) This shows the complex at a later time (t= 4000 ns) at which P139 (orange) is 
interacting with the hydrophobic pocket.   
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The P139 interaction with the Gαi1 hydrophobic pocket was followed by monitoring the 
solvent accessible surface area (SASA) of P139 over the 5 µs long trajectory. The SASA 
of P139 was 200 Å2 (t=0 ns), at the beginning of the trajectory, but decreased and reached 
its lowest SASA (80 Å2) during the period between 250 ns to 300 ns. After 3000 ns, the 
P139 SASA stayed at 120 Å2. Over the 5000 ns long trajectory, P139 entered and exited 
the hydrophobic pocket multiple times; at 1000 ns and 2500 ns it is out of the 
hydrophobic pocket (black line in Figure 17A). A similar trend was shown by following 
the P139 interaction energy with the Gαi1 hydrophobic pocket over the course of 5 µs 
long trajectory. The interaction energy between P139 and the Gαi1 hydrophobic pocket 
was close to zero at the start of trajectory, but dropped to a minimum of -7 kcal/mol 
between 250 ns to 300 ns. Then at 1000 ns and again at 2500 ns (black line in Figure 
17B), the interaction energy was close to zero when the SASA was at a maximum (black 
line in Figure 17A). Between 3000 ns to 4000 ns the interaction energy remained at a 
value of -5 kcal/mol. 
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Figure 17. IC-2 Loop P139 Interaction with Gαi Protein 
These plots show the change in the  
(A) solvent accessible surface area (SASA) and  
(B) the Van der Waals interaction energy for the P139 (CB2 IC-2 loop) interaction with 
the Gαi1 hydrophobic pocket. The red line represents the running average over 100 ns. 
Over the 5µs trajectory, P139 entered and exited the hydrophobic pocket multiple times. 
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IC-3 Loop Interactions with the Gαi α4 Helix 
 In the MD simulation starting structure, the CB2 IC-3 loop residue R229 was 
close to the Gαi α4 helix residue E308. A long lasting interaction between R229 and E308 
was observed between 2000 – 4000 ns, where the R229 (N) – E308 (O) distance stays 
below 4 Å (Figure 18A). An IC-3 loop interaction with the other residues on the Gαi α4 
helix was observed from 1.4 to 1.6 µs, when the CB2 IC-3 residue R229 “dove” down to 
interact with E297 and E298 (Figure 18B). After 2 µs, R229 interacted with Q304 and 
E308 on the Gαi α4 helix favoring an E208 interaction.  
 
 
 
Figure 18. IC-3 Loop R229 Interaction with Gαi α4 Helix Residue E308 
(A) A plot of the N-O distance between CB2 IC-3 loop residue R229 and Gαi α4 helix 
residue E308 versus simulation time (black line) is presented here. The green line at 4.0 
Å represents the maximum accessible distance between N and O (81). The red line 
represents the running average over 100 ns.  
(B) This figure shows the Gαi α4 helix in magenta and the CB2 IC-3 loop in cyan color at 
t=1533 ns.  
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Interaction Between CB2 TMH7/Hx8 Elbow Region and Gαi C-Terminus 
 At the start of the MD simulation, the CB2 receptor elbow region (TMH7/Hx8) 
residue R7.56 (302) was not interacting with the Gαi C-terminal α5 helix residue D350 (i-
4), it was pointing towards lipid (Figure 19A). However, an interaction between these 
two residues developed after 3µs in the trajectory. 
 
 
 
Figure 19. Interaction Between CB2 TMH7/Hx8 Elbow Region and Gαi C-Terminus 
This figure shows the interaction between the CB2 elbow region residue (R7.56, green 
carbons and blue nitrogens) and the Gαi C-terminal residue (D350, cyan carbons and red 
oxygens).  
(A) At t=0 ns R7.56 (orange) is pointing towards lipid, not towards D350 (i-4).   
(B) At t= 5 µs R7.56 is interacting with D350 (i-4).  
 
This elbow region interaction with the Gαi C-terminal α5 helix is followed by a slow 
decrease in the Cα distance (black line in Figure 20) between R7.56 (302) and D350 (i-4) 
after the start of the trajectory.  The long standing interaction between R7.56 (302) and 
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D350 (i-4) that is eventually established is reflected in the N - O distance between R7.56 
– D350 which stays under 4 Å after 3 µs of the trajectory (blue line in Figure 20).  
 
Figure 20. Plot of N – O Distance 
Between CB2 TMH7/Hx8 Elbow 
Residue R7.56 and Gαi C-
Terminus Residue D350 (i-4) as a 
Function of Time 
The black line in Figure 20 shows 
the decrease in the Cα distance 
between R7.65 (302) and D350 (i-
4) over the course of the trajectory. 
The blue line shows the decrease in 
the N-O distance between R7.65 
(302) and D350 (i-4). The green 
line at 4.0 Å represents the 
maximum accessible distance 
between N and O (81). The red and yellow lines represent the running average over 100 
ns.  
 
GDP Hydration 
 Over the 5 µs long MD simulation, a significant increase in the GDP hydration 
occurred. GDP is completely occluded by water at the end of 5 µs (Figure 21B and 21D) 
as compared to the beginning of the trajectory (Figure 21A and 21C). Only a small part of 
GDP is visible at the end of 5 µs (see Figures 21B and 21D). 
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Figure 21. GDP Hydration 
This figure shows GDP in VdW display with green carbons, blue nitrogens and red 
oxygens.  
(A) Shown in blue surface display is the water within 4 Å of GDP at the start of the 
trajectory (t = 0 ns). 
(B) Water within 4 Å of GDP at t = 5000 ns is shown in blue surface.  
(C) and (D) In these figures GDP has been rotated 1800 relative to the view shown in (A) 
and (B). Part C shows the water surrounding GDP at t=0 ns and D shows this at t = 5000 
ns.  
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The hydration of GDP during the trajectory was monitored by counting the number of 
waters within 4 Å of GDP and also by following the solvent accessible surface area 
(SASA) of GDP. 
 For the first microsecond of our trajectory, a slow increase in the number of water 
molecules surrounding GDP (within 4 Å) was observed from 16 to 24 molecules (black 
line in Figure 22A). Between 1.5 – 3.5 µs of the trajectory there were 24 water molecules 
surrounding GDP, but there was an increase in the number of water molecules from 24 to 
34 molecules after 3.5 µs (black line in Figure 22A). The initial increase in the number of 
water molecules surrounding GDP is also reflected in the increase in GDP SASA from 25 
Å2 to 125 Å2 for the first microsecond. During 1.5 – 2.5 µs of the trajectory, GDP SASA 
remained close to 125 Å2 (black line in Figure 22B). The second increase in the water 
influx after 3.5 µs is also reflected in the GDP SASA from 100 Å2 to 170 Å2 (Figures 22A 
and 22B).  
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Figure 22. Solvent Accessible Surface Area of GDP 
(A) The black line shows the increase in the number of water molecules within 4Å of 
GDP over the 5µs long trajectory.  
(B) The black line shows the increase in the solvent accessible surface area of GDP from 
25 Å2 to 170 Å2 over the 5µs long trajectory. The red line in both the figures represents 
the running average over 100 ns.  
 
 
GDP Hydrogen Bonding 
 In the initial CB2 / Gαi1 protein complex, there were 20 hydrogen bonds between 
GDP and surrounding Gαi1 residues and 10 hydrogen bonds between GDP and the water 
surrounding GDP. Over the 5 µs trajectory these numbers changed, with 10 hydrogen 
bonds between GDP and surrounding residues on the Gαi1 protein and 20 hydrogen bonds 
between GDP and the surrounding water by the end of the trajectory.  A slow decrease in 
the number of hydrogen bonds between GDP and surrounding Gαi residues was observed 
during first microsecond (black line in the Figure 23). A steady increase in the number of 
hydrogen bonds between GDP and surrounding water was observed during first 
microsecond (blue line in the Figure 23). This correlates well with increase in GDP 
SASA over the same time period (Figures 22A and 22B). After 3.5 µs, the number of 
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hydrogen bonds between GDP and water exceeds the number of hydrogen bonds with 
Gαi. This correlates well with the increase in GDP SASA over the same time periods 
(Figures 22A and 22B).  
 
Figure 23. GDP Hydrogen 
Bonding 
The black line here represents the 
number of hydrogen bonds 
between GDP and the Gαi protein 
and the blue line represents the 
number of hydrogen bonds 
between GDP and water over the 
5µs long trajectory. The red and 
yellow lines represent the running 
averages over 100 ns.  
 
 
 
 
Correlation Between GDP Hydration and Intracellular Loop Interactions  
 Over the 5 µs of the trajectory, all three CB2 intracellular loops interacted with the 
Gαi ras-like domain. As discussed above, a significant increase in GDP hydration was 
observed during the trajectory as well. 
IC-2 Loop Interactions and GDP Hydration 
 During first microsecond of the simulation, P139 on IC-2 loop established an 
interaction with the Gαi hydrophobic pocket (Figures 17A and 17B ), this was the result 
of  the reorientation of the G protein under the CB2 receptor (73). At the same time, a 
slow increase in the number of water molecules surrounding GDP and increase in GDP 
SASA was observed (Figures 22A, 22B and 23). These times correlate with periods in 
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which the IC-2 loop residue P139 was interacting with the Gαi hydrophobic pocket 
(Figures 17A and 17B). 
IC-3 Loop Interactions and GDP Hydration 
 During the initial 200 ns of the simulation, the CB2 IC-3 loop residue, R229 
interacted with the Gαi α4 helix residue, E308. Later, this interaction was observed for a 
longer period of time (2000 – 4000 ns) (Figure 18A). However, it is the R229 interaction 
with other Gαi α4 helix residues (E297 and E298; see Figure 18B) from 1.4 to 1.6 µs, that 
appears to be correlated with an increase in the number of waters within 4 Å of GDP and 
an increase in the SASA of GDP (Figures 22A and 22B). 
IC-1 Loop Interactions and GDP Hydration 
 The CB2 IC-1 loop residue, R66, interacted with the Gαi N-terminal helix residue, 
E28, between 1000 – 2800 ns and later after 3900 ns in the 5 µs long trajectory (Figure 
15B), but there was no significant increase in the hydration of GDP or increase in the 
SASA of GDP during these time periods of the simulation. 
 In summary (see Figure 24), our 5 µs long MD simulations suggest that the initial 
increase in the hydration of GDP occurs during the time when the IC-2 loop establish 
contacts with Gαi ras-like domain during the first microsecond of the simulation. Later, 
when the IC-3 loop residue R229 extends to reach E297 and E298 on the Gαi α4 helix on 
the ras-like domain of Gαi protein, another increase in the GDP hydration occurs. The 
final period of GDP hydration increase occurs when the TMH7/Hx8 “elbow” region 
interacts with the Gαi C-terminal α5 helix. 
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Figure 24. CB2 Intracellular Loops Contacting Gαi Protein and GDP Hydration 
(A) This figure shows the interactions of all the CB2 intracellular loops with the Gαi 
protein. The helical domain of the Gαi protein is shown in green. The GDP bound 
between the helical and ras-like domains of Gαi1 is represented in VdW display with 
carbons, nitrogens and oxygens colored green, blue and red respectively. The IC loops on 
the CB2 receptor are colored green, blue and cyan for IC-1, IC-2 and IC-3 respectively. 
This snapshot is at t=1500 ns in the 5µs long trajectory. 
(B) The blue, cyan and yellow points correspond to the increase in GDP hydration due to 
the initial IC-2 loop, IC-3 loop and elbow region interactions respectively with the Gαi1 
ras-like domain.  
 
 
 The interactions of all the three intracellular loops are shown in Figure 24 at 1500 
ns of the trajectory. The IC-2 and IC-3 loop interactions of CB2 receptor with the Gαi ras-
like domain that correlated with GDP hydration increases were the results of the loop 
“tugging” on the Gαi ras-like domain (Blue and cyan points in Figure 24B). These “tugs” 
allowed more water molecules to move into the pocket containing GDP. It is our 
hypothesis that this increase in hydration will facilitate the dissociation of GDP from Gαi 
protein. 
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Discussion 
 During the last decade, a lot of high-resolution X-ray crystal structures for various 
GPCRs have been solved (5,6,48-55,82) including one lipid receptor (S1P1) (3), but most 
of these are either missing parts of the IC loops, specifically IC-3, or there are other 
proteins attached to these loops for crystallization like lysozymes, nanobodies etc. There 
are X-ray crystal structures available for the G protein heterotrimer (Gαβγ) (26,57,58) 
with an unresolved C-terminal on Gα and Gγ. There is only one crystal structure of a 
GPCR/G-protein complex (β2-AR/Gs) available so far, which is missing the IC-3 loop. 
Here, the G-protein heterotrimer is stabilized with a nanobody inserted between the Gα 
and the Gβ subunits. This GPCR/G-protein complex (β2-AR/Gs) represents the empty 
state where GDP has left the G protein heterotrimer   
 We have shown here that an activated GPCR can trigger changes in a G-protein 
leading to its activation. Biochemical and biophysical data suggests the importance of the 
C-terminus and α4-β6 loop of the Gα proteins (63,71,72) in receptor coupling. The 
interaction between the IC-2 loop on the receptor with G-protein has been shown to be 
critical by F139A mutagenesis studies for β2-AR/Gs system (69). The only GPCR/G-
protein complex (β2-AR/Gs) crystal structure showed the interaction between F139 and a 
hydrophobic pocket on the ras-like domain of Gs-protein (32). The involvement of the 
IC-3 loop with the Gα α4 helix (78,79) and α4-β6 loop (71,72) has also been shown to be 
important for G-protein activation. However, the molecular mechanism by which the 
receptor catalyzes the G-protein activation is not completely understood.  
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 In this work, we report the role of the IC loops of the CB2 receptor in the 
activation of the Gαi protein. To understand the dynamic nature of these interactions we 
undertook multi-microsecond molecular dynamics simulations of the CB2 / Gαi1β1γ2 
protein complex, which was based on the empty state crystal structure of the β2-AR with 
Gαs protein after GDP dissociation (32). In this crystal structure the IC-3 loop has not 
been fully resolved and a nanobody is used to artificially stabilize the complex for 
crystallization. Our MD simulations are unbiased as there is no nanobody, T4-lysozyme 
or any other constraint being used.  
 Our 5 µs long MD results suggest that the initial interactions between intracellular 
loops 2 and 3 of the CB2 receptor and the ras-like domain of Gαi protein triggers 
increasing hydration of GDP  by “tugging” on the Gαi ras-like domain from both sides, 
the IC-3 loop interact with the Gαi α4 helix on one side of the ras-like domain and the IC-
2 loop interact with the opposite side of on the Gαi ras-like domain, specifically with the 
hydrophobic pocket  comprising  the Gαi N-terminus (V34), β1 and β2 sheets (L194 and 
F196), and α5 helix (I344, I343, T340 and F336) on the Gαi ras-like domain (Figure 24).  
Role of IC-2 Loop in the Activation of Gαi1pProtein 
 In our simulations, P139 showed a hydrophobic interaction with the Gαi protein. 
The importance of this interaction to G-protein activation is underscored by mutagenesis 
studies which demonstrate that a β2-AR F139A mutation significantly impairs β2-AR 
coupling to Gαs (69). 
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In our simulation, this is the main loop interaction that causes an increase in GDP 
hydration and SASA (Figures 17A, 17B and Figures 22A, 22B). For the CB2 / Gαi1β1γ2 
protein complex, Zheng et al., have reported that a P139A mutation results in the loss of 
coupling with Gαi protein, thus supporting our simulations (70). 
 
 
 
Figure 25. IC-2 Loop P138 Interaction with Gαi Protein 
These plots show the change in the  
(A) solvent accessible surface area (SASA) and  
(B) the Van der Waals (VdW) interaction energy for the P138 (CB2 IC-2 loop) interaction 
with the Gαi1 hydrophobic pocket. The red line represents the running average over 100 
ns.  
 
 
There is another proline in the IC-2 loop, P138 that is adjacent to P139. Figure 25 
illustrates that P138 does not contribute to the CB2 / Gαi1β1γ2 protein interactions (Figures 
25A and 25B) despite the fact that P139 does not interact throughout the simulation with 
the Gαi1 hydrophobic pocket, instead it enters and exits the Gαi1 hydrophobic pocket 
multiple times during the simulation. 
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Role of IC-3 Loop in the Activation of Gαi1 Protein 
 The importance of the Gαi α4 helix residues, Q308 and E308, in Gαi protein 
activation has been shown by Hamm and co-workers in the 5-HT1B / Gαi protein system 
(71,78,79). In our simulation, the CB2 IC-3 loop residue, R229, interacts with the α4 helix 
residue E308 between 2000 – 4000 ns (Figure 18A). However a significant increase in 
the GDP hydration and SASA was observed during another IC-3 loop interaction when 
R229 interacted with the α4 helix residues E297 and E298 (Figures 18A and 18B). 
Although this interaction only lasted for 200ns, it suggested that the further down the α4 
helix the IC-3 loop can reach, the more the influence on GDP hydration. In our 
simulation, R229, interacted with Gαi α4 helix residues E308 for more of the trajectory 
than with the Gαi α4 helix residue Q304 (Figure 26).  Figure 26 shows that the N-O 
distance for this pair of residues rarely decreases below 4 Å, the threshold distance for a 
salt bridge (81). 
 
Figure 26. IC-3 Loop Residue 
R229 Interaction with Gαi α4 
Helix Residues Q304 
The black line in the Figure 
represents the N-O distance 
between R229 on the IC3 loop of 
the CB2 receptor and Q308 on the 
α4 helix of the Gαi protein. The 
green line at 4.0 Å represents the 
maximum accessible distance 
between N and O (81). The red line 
represents the running average over 
100 ns. It is clear here that the N-O 
distance rarely decreases below 4 
Å, the threshold distance for a salt bridge. 
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Interaction Between TMH7/Hx8 Elbow Region and C-Terminus of Gαi Protein 
 
 In our starting CB2 / Gαi1β1γ2 protein complex, the CB2 receptor elbow region 
(TMH7/Hx8) residue R7.56 (302) was pointing towards lipid (Figure 19A), however 
from 3.5 µs to 5 µs in the trajectory, R7.56 (302) has developed a long lasting interaction 
with the Gαi C-terminal α5 helix residue D350 (i-4). This interaction also contributes to 
the increase in GDP hydration (yellow rectangle in Figure 24B) and an increase in GDP 
SASA. 
 In summary, the Gαi1 ras –like domain experiences interactions from multiple 
domains of the CB2 receptor. These include the CB2 TMH7/Hx8 R7.56/ Gαi1 C-terminal 
α5 helix residue D350 (i-4) interaction; the CB2 IC-3 loop/ Gαi α4 helix interaction; the 
CB2 IC-2 loop/ Gαi1 hydrophobic pocket interaction; and the CB2 IC-1 loop / Gαi N-
terminal helix interaction. These cover all the Gαi ras –like domain regions exposed to 
the CB2 receptor. 
Conclusions 
Our MD simulations shows the contribution that the intracellular regions of the 
CB2 receptor make to the interaction with the Gαi protein. Many of these interactions lead 
to an increase in GDP hydration. These IC regions include all IC loops and the 
TMH7/Hx8 elbow region .Our ultimate goal is to achieve the activated state of Gαi1β1γ2 in 
which GDP has been dissociated from Gαi protein. While there is significant progress in 
GDP hydration by 5 µs, the simulations have not yet achieved 100% GDP hydration and 
activation has not yet occurred. At this writing, the simulation continues!
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Abstract 
 Activation of CB2 has been shown experimentally to produce coupling to Gαi 
inhibitory protein. This receptor is activated by an endogenous, membrane derived 
ligand, sn-2-arachidonoylglycerol (2-AG). In turn, the activated receptor activates the 
heterotrimeric Gi protein. There is a growing body of literature which suggests that 
GPCRs can exist as dimers and higher order oligomers in the cellular membrane. 
Multiple dimer interfaces for these receptors have been proposed including the 
TMH4/TMH5 region and TMH1/TMH1 region for D2 receptor, and the TMH4/TMH5 
region for rhodopsin. In addition, it has been shown that the optimum signaling complex 
for a homodimer is one that includes one receptor in the activated state dimerized with 
one in inactive state.  
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 In this work, we studied the CB2 active (R*)/ inactive (R) homodimer interface. 
Based on the unpublished data from our collaborator and using the chemokine CXCR4 
crystal structure as a template, we built the CB2 R/ R* homodimer. We then modeled the 
CB2 R/R* homodimer as a singling complex with Gαi1β1γ2 protein. To study the stability 
of the CB2R R*/ Gαi1β1γ2 complex, molecular dynamics simulations in a POPC bilayer 
were performed. Results from two independent trajectories of 500 ns each, suggest that 
on TMH6, A6.60 (270) and H6.57 (267) and on TMH5 L5.40 (191), L5.41 (192), L5.44 
(195), L5.45 (196), F5.61 (202) are involved in the CB2 R R* homodimer interface. 
However, we found that the complex formed between the CB2 R R* homodimer and the 
Gαi1β1γ2 protein was not stable. Work on this project was halted to focus on the CB2 R*/ 
Gαi1β1γ2 signaling complex described in Chapters 1 and 2.  
Introduction 
 In early work on G-protein coupled receptors (GPCR), these receptors were 
assumed to act as monomers with each receptor signaling through its own G-protein. 
More recently, there has been a growing body of literature that has focused on the 
possibility that GPCRs may exist and act as dimers or higher order oligomers (83-86). If 
such species form and signal, there is likely a defined interface for dimerization. Early 
work on the dopamine D2 receptor identified the TMH4/TMH5 region of this receptor as 
its homodimer interface. A cysteine crosslinking study of the inverse agonist bound 
dopamine D2 receptor identified a symmetric TMH4-TMH5 homodimer interface (87) 
consistent with the atomic force microscopy (AFM) – based model of the dimer interface 
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of dark state rhodopsin (88). An additional TMH1/TMH1 interface was later found for 
D2 in its oligomeric state (89) and a different set of TMH4 residues was found to form 
the dimeric interface in activated D2 (90). The symmetric TMH4-TMH5 interface has 
been predicted computationally for numerous GPCRs (91,92).  
Importance of GPCR Dimerization in GPCR Function 
 Do all GPCR dimers have a TMH4/TMH5 interface? Recent GPCR crystal 
structures suggest alternate interfaces such as TMH5/TMH6 and TMH7/TMH1, but are 
these physiologically relevant? The case against these crystallographic interfaces being 
physiologically relevant is that for crystallization, receptors are purified and detergent 
solubilized as monomers. The formation of parallel and anti-parallel dimers occurs during 
crystallogenesis and probably reflects differences in the most energetically favorable 
interactions under the crystallography conditions (54). In addition, modifications made to 
GPCR structure (such as the insertion of T4-lysozyme into the IC-3 loop to promote 
crystallization) may also favor certain interfaces. This may be the case for the µ-opioid 
(OPRM1) receptor with its close association of T4-lysozymes (5). On the other hand, the 
case for these interfaces being physiologically relevant is that the interfaces that are 
emerging from crystallographic data of unrelated GPCRs do suggest the propensity for 
certain interfaces to form dimers. For example, the TMH5-TMH6 interface found in the 
OPRM1 has also been found in five crystal structures of the CXCR4 receptor complexed 
with small molecule and cyclic peptide antagonists (52).  
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 In the absence of experimental information, there are methods that have been 
developed to predict dimer interfaces. Weinstein and co-workers, for example, have 
proposed a hydrophobic mismatch approach for prediction of dimer interfaces for GPCRs 
(93). This method is based on the calculation of free energy cost for protein-bilayer 
hydrophobic mismatch. The work shown here benefits from preliminary crosslinking data 
from the Zhao-Hui Song lab. This data suggests that the CB2 homodimer interface 
involves residues on the EC end of TMH6. 
Functional Relevance of Dimerization 
 Functional studies of GPCR heteromers have shown that activating one receptor 
in the presence of a second receptor can modulate the activity of second receptor alone 
(94-96).  Javitch and co-workers have shown for the dopamine D2 receptor homodimer, 
that for a signaling unit, consisting of a dopamine D2 homodimer of an inactive (R) and 
activated (R*) receptor in complex with a single heterotrimeric G protein, the unit 
appears to be maximally activated by agonist binding to a single protomer. Agonist 
binding to both the protomers actually reduced signaling (97).  
 The cannabinoid CB1 receptor has been shown to form homodimers and  
heterodimers with dopamine D1 receptor and opioid receptors (98). No dimers of the 
cannabinoid CB2 receptor (which belongs to GPCR Class A) have yet been reported. In 
the current work, we studied the formation of a CB2R*/ R homodimer and then CB2R R*/ 
Gαi1β1γ2 complex as a signaling unit. 
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Methods  
Crosslinking and Immunoblotting 
 The CB2 receptor has been shown to exhibit high constitutive activity (19).  For 
this reason, crosslinking experiments (performed by our collaborator, Dr. Zhao-Hui Song) 
were conducted in the absence of exogenous agonist. The crosslinker HgCl2 was applied 
to intact adherent cells stably expressing the indicated cysteine mutants as described (99). 
The crosslinking reaction was stopped by addition of 10 mM N-ethylmaleimide, and the 
cells were harvested. The extracted proteins were resolved by SDS/PAGE and 
immunoblotting was conducted using an anti-CB2 antibody (unpublished work). 
Molecular Modeling: CB2 Active and Inactive Receptor Models  
 The inactive (R) and active (R*) CB2 model employed in this study were taken 
from our previously published microsecond-long simulation of the activation of the CB2 
receptor by the endogenous ligand, 2-AG, via the lipid bilayer (17).  To represent the 
inactive state of the CB2 receptor, we chose frame 288 from trajectory A in which the salt 
bridge between TMH3 and TMH6 is intact. The α-carbon distance between R3.55 (136) 
and D6.30 (240) was 11.3 Å and the heteroatom distance N (R3.55 (136)) – O (D6.30 
(240)) was 3.4 Å. To represent the activated state of the CB2 receptor, we chose frame 
322 from trajectory E in which the salt bridge between TMH3 and TMH6 is broken. The 
α-carbon distance between R3.55 (136) and D6.30 (240) was 15.2 Å and the heteroatom 
distance N (R3.55 (136)) – O (D6.30 (240)) was 12.7 Å (17).  
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Construction of the CB2 R/R* Homodimer Interface 
 CB2 R/R* homodimer was built using the X-ray crystal structure of chemokine 
CXCR4 receptor as a template (52). Both CB2 R and CB2 R* were palmitoylated at C320 
and were truncated at G232. Experimental information from our collaborator, Dr. Zhao-
Hui Song, suggested that residues at the EC and of TMH6 were involved in the CB2 
homodimer interface. We constructed the initial CB2 homodimer model with a 
TMH5/TMH6 interface. For the TMH5/TMH6 dimer interface, both CB2 R and CB2 R* 
receptors were placed in relative orientations such that A6.60 on both receptors were 
close to each other. To relieve steric clashes between CB2 R and R* both the receptors 
were optimized in the x-y-z directions. The intracellular and extracellular loops on the 
CB2 R and CB2 R* were detached during the relative placement of both the CB2 receptors 
and reattached using the Maestro module from Schrodinger, LLC, New York, NY after 
the final placement of CB2 receptors. The CB2 R/ R* homodimer was minimized 
following a two step protocol. In the first step, a minimization was performed using a 
Polak-Ribier conjugate gradient and the OPLS2005 all atom force field in the 
Macromodel module from Schrodinger, LLC, New York, NY. The transmembrane 
regions and helices 8 of CB2R and CB2 R* were frozen and a minimization was 
performed for 20000 steps or until the system reached the 0.05 kJ/mol gradient in a 
distance-dependent dielectric of 80 (ε = 80). In the second step, both CB2R and CB2 R* 
were frozen except for the sidechains of the residues L5.40 (191), L5.41 (192), L5.44 
(195), L5.45 (196), F5.61 (202) on TMH5 and the minimization was performed for 
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10000 steps or until the system reached the 0.05 kJ/mol gradient in a distance-dependent 
dielectric of 1 (ε = 1). 
Calculation of Dimer Interface Interaction Energy 
 The interaction energies for the dimer interfaces of the initial CB2 R/ R* 
homodimer model and X-ray crystal structure of chemokine CXCR4 homodimer were 
calculated using the OPLS2005 all atom force field in Macromodel module from 
Schrodinger, LLC, New York, NY using the component interactions script. 
G Protein Modeling 
 As the crystal structure of Gαi1β1γ2 heterotrimer (26) is missing the Gαi1 C-
terminus and Gγ2 C-terminus, NMR structures (27,28) were used to complete the 
structure as published (100). Lipidation sites were attached to Gαi1β1γ2 heterotrimer, a 
palmitic acid was attached to the N-terminus of Gαi1 at Cys3 (29),   a myristic acid was 
attached to Gly2 of Gαi1 (30) and a geranylgeranyl group was attached to Cys 68 in the 
Gγ2 C-terminus (31).   
CB2 R/R* / 2-AG/ Gi Protein Complex 
 The relative orientations of Gαi1β1γ2 under the CB2 R/R* homodimer was based 
on the orientation proposed by Han et al. (97). The C terminal α5 helix was inserted into 
the active CB2 R* receptor and the N terminal helix of Gαi was placed under the inactive 
CB2 R receptor by rotation and translation in the x- y- z directions of the Gαi1β1γ2 
heterotrimer using the Maestro module from Schrodinger, LLC, New York, NY.  
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Molecular Dynamics Simulation of the CB2 Homodimer /Gαi1β1γ2 Complex in lipid 
Bilayer 
 In the CB2 R/R* /Gαi1β1γ2 protein complex, the CB2 R (inactive) receptor residue 
E1.49 was protonated and the CB2 R* (active) receptor residues E1.49, D6.30 and D3.49 
were protonated as published previously (17). The CB2 R/R* /Gαi1β1γ2 protein complex 
was oriented such that the amphipathic helix 8 was approximately parallel to the plane of 
the phospholipid membrane at the water/phospholipid interface. The simulation cell 
system was constructed with the replacement method, using scripts derived from 
CHARMM-GUI (33). The final size of the simulation cell was 130.0Å x 130.0Å x 170.6 
Å and contained 423 lipid molecules for a total of 279647 atoms. The system was 
neutralized with NaCl added such that the ionic strength was approximately 0.1M.The 
system was minimized using CHARMM (38) for 500 steps of steepest decent to 
eliminate the initial poor contacts with no restraints applied to the protein. The system 
was then minimized for 20,000 steps of conjugate gradient minimization using NAMD 
(39). The minimized system was heated in 10K increments to 310K with restraints on the 
protein (using a force constant of 10 kcal/mol/Å2 for the backbone and 5.0 kcal/mol/Å2 
for the sidechains), and on the POPC phosphates (using force constant of 5.0 
kcal/mol/rad2) and a harmonic dihedral restraint on the POPC cis double bond and the 
glycerol C2 chiral center (using force constant of 500 kcal/mol/rad2). At each increment, 
500 steps of minimization were performed followed by 10ps of dynamics at the higher 
temperature. Equilibration was performed for 25 ps for the first 3 steps and 200 ps for the 
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next 3 steps of molecular dynamics and then the restraints were released in 6 steps. 
Production dynamics was performed on a Blue Gene supercomputer (41) located at the 
Thomas J. Watson Research Center. Two independent trajectories of 500 ns each were run 
for this complex. All analysis was performed using visual molecular dynamics (42). 
Results 
Identification of CB2 Crosslinks (unpublished data) 
 Substituted cysteine accessibility method (SCAM) performed on the CB2 receptor 
at the Song laboratory identified that a CB2 A6.60C mutant formed a spontaneous CB2 
homodimer. Upon treatment of HgCl2, H6.57C and A6.60C expressing cells had 
immunoreactive bands of about double the size of the bands of the wild-type CB2 
expressing cells. In the presence of dithiothreitol (DTT), the higher molecular weight 
immunoreactive bands disappeared, indicating the higher sized bands are crosslinked 
monomers of CB2 receptor (Unpublished data).  
CB2 R/R* Homodimer 
 The initial CB2 R/R* homodimer was based on the crystallographic TMH5-TMH6 
dimer interface reported in the X-ray crystal structure of chemokine CXCR4 receptor 
bound to a cyclic peptide CVX15 and a small molecule IT1t (52). In the CB2 R/ R* 
homodimer, the extracellular end of CB2 R* TMH6 is close to extracellular end of CB2 R 
TMH6 (white surface in the Figure 27 and A6.60 (red tubes) in Figure 28). The Cα 
distance between A6.60 (270) on CB2 R and CB2 R* was 6 Å. The extracellular ends of 
TMH6 (A6.60) on CB2 R and R* together also positioned transmembrane regions of  
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TMH5 on CB2 R and R* crossing each other bringing together the hydrophobic residues 
L5.40 (191), L5.41 (192), L5.44 (195), L5.45 (196) and F5.61 (202) (Figure 28). L5.40 
(191) on the CB2 R was facing L5.41 (192) on the CB2 R* and L5.41 (192), L5.44 (195) 
were facing L5.44 (195) on the CB2 R* making an asymmetric TMH5-TMH5 dimer 
interface. 
 
Figure 27. CB2 R/ R* 
Homodimer 
This figure shows the CB2 R* 
receptor in orange and the CB2 R in 
purple. The dimer interface on 
TMH5 CB2 R is in yellow surface 
and the dimer interface on TMH5 
CB2 R* is in green surface. The 
dimer interface on the extracellular 
ends of TMH6 CB2 R and R* is 
shown in red surface (A6.60 and 
H6.57).  
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Figure 28. TMH5-TMH6 Dimer 
Interface Residues 
In this figure part of the CB2 R* 
receptor is shown in orange and 
part of the CB2 R receptor is shown 
in purple. The residues on TMH5 
that are part of the dimer interface 
on CB2 R are labeled yellow (L5.40 
(191), L5.41 (192), L5.44 (195), 
L5.45 (196), F5.61 (202)) and the 
residues on TMH5 that are part of 
the dimer interface on CB2 R* are 
labeled green (L5.40 (191), L5.41 
(192), L5.44 (195), L5.45 (196), 
F5.61 (202)). A6.60 and H6.57 on 
TMH6, which is part of the TMH6 
dimer interface on CB2 R and CB2 
R* are colored and labeled red.  
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Figure 29. Hydrogen Bond 
Between A6.60 - T271 
This figure shows TMH6 and the 
EC3 loop on CB2 R in purple and 
TMH6 and the EC3 loop on CB2 
R* in orange. The hydrogen bond 
between A6.60(270) on TMH6 
CB2 R* and T271 (EC3) on CB2 
R is shown by the black dotted 
line. 
 
 
 
 
 
 
Interaction Energies of the Homodimer Interface 
 The total interaction energy for the TMH5-TMH6 CB2 R/R* homodimer interface 
was 17.8 kcal/mol. The hydrogen bond between A6.60 (270) of CB2 R* and T271 on 
EC3 loop (Figure 29) of CB2R TMH6 contributed 7.8 kcal/mol and the VdW interaction 
energy between TMH5 residues L5.40 (191), L5.41 (192), L5.44 (195), L5.45 (196), 
A5.48 (199), F5.61 (202) on both CB2 R and R* contributed the rest of the dimer 
interface interaction energy (see Table 1). 
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Table 1. Interaction Energy of CB2 Homodimer 
 
CB2 R* 
(Active) 
CB2 R 
(Inactive) 
Interaction Energy 
(kcal/mol) 
L5.41(192) L5.44(195) -2.5 
L5.44(195) L5.44(195) 
L5.45(196) 
-1.2 
-3.1 
L5.45(196) A5.48(199) 
F5.51(202) 
-1.2 
-1.1 
A6.60(270) A6.60(270) 
T271(EC3) 
-1.9 
-7.8 
 Total -17.8 
 
 
The total computed VdW energy of interaction for the X-ray crystal structure of 
chemokine CXCR4 receptor was -18.4 kcal/mol with the major contribution coming from 
the interaction between W5.34 (195) and L267 on EC3 loop and rest from TMH5 
residues L5.33 (194), V5.36 (197), V5.37 (198), F5.40 (201), M5.44 (205) of CXCR4 
receptors (Table 2). 
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Table 2. Interaction Energy of CXCR4 Homodimer 
 
CXCR4 
A 
CXCR4 
B 
Interaction Energy 
(kcal/mol) 
L5.33(194) L267(EC3) -1.2 
W5.34(195) L267(EC3) -11.7 
V5.36(197) V5.36(197) -1.5 
V5.37(198) V5.36(197) 
F5.40(201) 
-1.0 
-1.9 
M5.44(205) M5.44(205) -1.1 
 Total -18.4 
 
 
Orientation of Gαi1β1γ2 Protein Relative to CB2 Homodimer in the CB2 R R* / Gαi1β1γ2 
Protein Dock 
 The initial heterotrimer Gαi1β1γ2 protein dock with the CB2 R/R* homodimer 
(Figure 30) was based on the orientation of G protein with the GPCR homodimer 
proposed by Javitch and Weinstein for the dopamine D2 receptor/ Gq protein complex 
system (97). In this complex, the Gα protein interacts with the active (R*) receptor by 
inserting its C terminal α5 helix between the TMH3-TMH5-TMH6 opening on the GPCR 
and the Gα N terminus was placed under the inactive (R) receptor (Figures 5c and 5d in 
reference 18). In the CB2 R R*/ Gαi1β1γ2 complex, the C terminal α5 helix of the Gαi1 
protein (yellow helix in Figure 30) was placed between the opening made by TMH3- 
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TMH5-TMH6-TMH7 region on the active CB2 R* receptor and the N terminus of the 
Gαi1 protein was placed under the inactive CB2 R receptor (Figure 30). This orientation of 
Gαi1β1γ2 protein placed the Gβ1 and Gγ2 subunit of the heterotrimer under the inactive 
CB2 receptor. Figure 30 illustrates the initial CB2 R R* homodimer bound to 2-AG / 
Gαi1β1γ2 complex model. 
 
Figure 30. CB2 Homodimer/ 
Gαi1β1γ2 Complex 
The initial 2-AG/CB2 R R*/ 
Gαi1β1γ2 complex is presented here. 
The CB2 R* receptor is shown in 
orange bound to 2-AG (VdW green 
carbons and red oxygens) and the 
CB2 R receptor is shown in purple. 
The CB2 R/R* dimer interface is 
shown in green and yellow surfaces 
on TMH5 of CB2 R* and CB2 R 
respectively. CB2 R/R* dimer 
interface on TMH6 is shown in red 
surface. The Gα subunit of the G 
protein heterotrimer is in magenta 
with its C terminal helix in yellow, 
Gβ is in blue and Gγ is in cyan. 
GDP is bound between the helical 
and ras-like domains of Gα and is 
shown in VdW display with carbons, nitrogens and oxygens colored green, blue and red 
respectively.  
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Molecular Dynamics Simulations 
 To study the dynamics of the CB2 R R*/ Gαi1β1γ2 complex in physiological 
conditions, all atom, fully hydrated POPC lipid bilayer molecular dynamics (MD) 
simulations were performed on this complex system. Results from two independent 500 
ns trajectories are discussed below. 
Extracellular End of TMH6 in the TMH5-TMH6 Dimer Interface of CB2 R/ R* 
Homodimer  
 In the starting structure of the CB2 R R* homodimer in complex with Gαi1β1γ2 
protein, the extracellular ends of the TMH6s of CB2 R and CB2 R* were close to each 
other (Figures 31A and 31C). The Cα distance between A6.60 (270) CB2 R and A6.60 
(270) CB2 R* was 7.7 Å for Trajectory 1 and 5.7 Å for Trajectory 2 in the starting 
structure. During the initial 50 ns this distance stayed under 10 Å for both the trajectories 
but after 50 ns the distance increased above 10 Å for Trajectory 1. In Trajectory 2, this 
distance stayed around 12 Å, but decreased below 10 Å at 65 and 150 ns (Figure 33A). 
After 500ns of production dynamics, A6.60 (270) CB2 R and A6.60 (270) CB2 R* were 
14.7 Å apart in Trajectory 1 and 10.9 Å apart in Trajectory 2 (Figures 31B and 31D).  
 SCAM results provided by our collaborator, Dr. Zhoa-Hui Song also suggested 
involvement of H6.57(267) in the CB2 homodimer interface. The Cα distance between 
H6.57(267) CB2 R and H6.57(267) CB2 R* was monitored for both the trajectories in the 
500 ns long MD simulations. This distance was 13.6 Å and 13.4 Å for Trajectory 1 and  
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Trajectory 2 respectively at the start of CB2 R R* homodimer /Gαi1β1γ2 protein complex  
trajectory (Figure 32A and 32C). 
85 
 
 
 
Figure 31. Relative Location of TMH6 Residue A6.60 in CB2 R/ R* Homodimer 
Figures A and C show the Cα - Cα distances between A6.60(270) on CB2 R and CB2 R* 
at the beginning t=0 ns of Trajectory 1 and Trajectory 2 respectively. 
Figures B and D show the Cα - Cα distances between A6.60 (270) on CB2 R and CB2 R* 
at the end t=500 ns of Trajectory 1 and Trajectory 2 respectively. 
Here, only TMH6 from each protomer is illustrated. TMH6 in CB2 R is shown in purple, 
while CB2 R* is shown in orange. The Cα of A6.60 (270) on each helix is colored red. 
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Figure 32. Relative Location of TMH6 Residue H6.57 in CB2 R/ R* Homodimer 
Figures A and C show the Cα - Cα distances between H6.57(267) on CB2 R and CB2 R* 
at the beginning t=0 ns of Trajectory 1 and Trajectory 2 respectively. 
Figures B and D show the Cα - Cα distances between H6.57(267) on CB2 R and CB2 R* 
at the end t=500 ns of Trajectory 1 and Trajectory 2 respectively. 
Here, only TMH6 from each protomer is illustrated. TMH6 in CB2 R is shown in purple, 
while CB2 R* is shown in orange. The Cα of H6.57(267) on each helix is colored red. 
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For the first 20 ns of Trajectory 1, the Cα – Cα distance between H6.57 – H6.57 
decreased to below 10 Å and then remained above 10 Å. In the case of Trajectory 2, this 
distance never decreased below 10 Å, remaining instead 18 Å throughout the trajectory 
(Figure 33B). At the end of 500ns in the MD simulations, the Cα distance between 
H6.57(267) CB2 R and H6.57 (267) CB2 R* was 19.5 Å in Trajectory 1 and 18.4 Å in 
Trajectory 2 (Figures 32B and 32D). 
 
 
 
Figure 33. Plots of Distance versus Simulation Time for the TMH6 Dimer Interface 
A plot of Cα- Cα distance as a function of simulation time is shown here for the A6.60 
(270) and H6.57(267). Trajectory 1 results are shown in black and Trajectory 2 results are 
in blue with the running averages over 100 ns represented by the red and magenta lines 
respectively. The green lines at 7 Å and 10 Å correspond to the distance range for 
crosslink formation between two cysteines using HgCl2. These results indicate that the 
residues were only occasionally within the correct distance range for crosslinking.  
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Transmembrane Helix 5 (TMH5) Dimer Interface Interaction Energy 
 In the CB2 R R* homodimer model TMH5 hydrophobic residues L5.40 (191), 
L5.41 (192), L5.44 (195), L5.45 (196) and F5.61 (202) on CB2 R were facing the 
corresponding residues on CB2 R* (Figure 28) with nearly half of the dimer interface 
interaction energy (8.9 kcal/mol from total of 17.8 kcal/mol) coming from these 
interactions. The VdW interaction energy between these hydrophobic pairs was followed 
over the 500 ns long trajectories. For both the trajectories the VdW interaction energy 
between the hydrophobic resides on TMH5 on CB2R and CB2 R* remained close to -14 
kcal/mol (Figure 34). 
 
Figure 34. TMH5 Dimer 
Interface Interaction Energy 
 This plot shows the change in the 
Van der Waals interaction energy 
for the TMH5 residues (L5.40 
(191), L5.41 (192), L5.44 (195), 
L5.45 (196) and F5.61 (202)) 
between CB2 R and CB2 R* for 
Trajectory 1 (black line) and for 
Trajectory 2 (blue line). The red 
and magenta lines represent the 
running average over 100 ns for 
Trajectory 1 and Trajectory 2 
respectively. 
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The Orientation of the Gαi1β1γ2 Heterotrimer Relative to the CB2 R/ R* Homodimer  
 In our initial CB2 R R*/ Gαi1β1γ2 complex, the C terminal α5 helix of Gαi1 protein 
was placed in the opening in the TMH3-5-6-7 region on the active CB2 R* receptor and 
the N terminus of the Gαi1 protein was placed under the inactive CB2 R receptor (Figure 
29). This placement of G protein was based on the dopamine D2 receptor work 
performed by Javitch , Weinstein and co-workers (97).  
 We monitored the changes in the CB2 R R*/ Gαi1β1γ2 complex over the 500 ns 
long MD simulations. In the initial orientation of Gαi1β1γ2 protein, the C terminal α5 
helix of Gαi1 was placed close to the plane of the lipid membrane (green helix in Figures 
35A and 35C) in the opening made by the TMH3-5-6-7 region on the active CB2 R* 
receptor. During 500 ns of MD the Gαi1β1γ2 heterotrimer changed its orientation under 
the CB2 R R* homodimer.  The C terminal α5 helix of Gαi1 left the CB2 R* receptor 
opening by rolling with the Gαi1β1γ2 in such a way that the helical domain of Gαi1 moved 
close to the membrane (Figures 35B and 35D). This change in the orientation of 
Gαi1β1γ2 heterotrimer under the CB2 R R* homodimer was observed for Trajectory 1, as 
well as Trajectory 2. 
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Figure 35. Change in the 
Orientation of Gαi1β1γ2 
Protein 
This figure illustrates the 
change in the orientation of 
Gαi1β1γ2 protein relative to 
the CB2 R/ R* homodimer. 
CB2 R is shown in purple, 
CB2 R* in orange and 
Gαi1β1γ2 protein in green 
with C-terminal α5 helix of 
Gαi1 protein in green 
cylinder.  
Figures A and C show the 
position of the Gαi1β1γ2 
protein relative to CB2 R/ 
R* homodimer at the start 
(t=0 ns) of Trajectory 1 and 
Trajectory 2 respectively. 
Figures B and D show the 
rotation in the Gαi1β1γ2 
protein at the end (t=500 ns) 
of Trajectory 1 and 
Trajectory 2 respectively. A 
rolling motion in the 
Gαi1β1γ2 protein is observed 
under the CB2 R R* 
homodimer at the end of 
500 ns in both the 
trajectories. 
 
 
Discussion 
 The involvement of TMH4 and TMH5 in the dimer interface of GPCRs has been 
reported by various groups (86,87,89,90). The X-ray crystal structures of chemokine 
receptor showed TMH5/TMH6 as crystallographic dimer interface for CXCR4 receptor 
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(52). The μ-opioid receptor was crystalized with two different dimer interfaces, 
TMH5/TMH6 and TMH1-TMH2-Hx8 (5). 
 In our work we modeled the CB2 R R* homodimer Gαi1β1γ2 protein signaling 
complex based on the work of Javitch and Weinstein which showed that an inactive (R) 
and activated (R*) receptor in complex with a single heterotrimeric G protein is the 
maximally activated signaling unit for dopamine D2 dimers (97). Furthermore we 
performed all–atom, fully hydrated lipid bilayer molecular dynamics simulations on this 
complex to study the stability of this signaling unit. 
Role of Extracellular End of TMH6 in CB2 R/ R* Homodimer Interface 
 The Cα – Cα distance range for two cysteines to be crosslinked using HgCl2 as 
crosslinker is 7 – 10 Å (44,45). Our MD results suggest that the A6.60 (CB2 R) – A6.60 
(CB2 R*) Cα distance stays below 10 Å for first 50 ns in Trajectory 1 and Trajectory2  
suggesting that A6.60 on the extracellular end of TMH6 is part of the CB2 dimer 
interface.  The Cα – Cα distance between H6.57 (CB2 R) – H6.57 (CB2 R*) was observed 
below 10 Å for only 20 ns in Trajectory 1, also suggesting involvement of H6.57 in the 
CB2 dimer interface. However, the fact that these distances do not spend a significant part 
of the entire trajectory in correct proximity suggests that the dimer interface is less likely 
to occur. A6.60 and H6.57 are two amino acids apart and thus not on the same face of 
TMH6 (Figures 31 and 32), therefore A6.60 on CB2 R faces A6.60 on CB2 R*, but H6.57 
on CB2 R does not face H6.57 on CB2 R* (Figure 28). For H6.57 on CB2 R to face H6.57 
on CB2 R*, a rearrangement in the faces of TMH6 would be needed as proposed by Guo 
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et al. for the dopamine D2 receptor TMH4-TMH5 dimer interface. The rearrangement in 
the dimer interface would be very challenging to capture by MD. 
Role of TMH5 in CB2 R/ R* Homodimer Interface 
 
 On TMH5 residues L5.40 (191), L5.41 (192), L5.44 (195), L5.45 (196), F5.61 
(202) were packed on both CB2 receptors contributing nearly half of the interaction 
energy in our CB2 R/R* homodimer model (Table 1). This is in agreement with the 
crystallographic dimer interface as seen in the CXCR4 crystal structure (Table 2). The 
energy of interaction between TMH5 residues L5.40 (191), L5.41 (192), L5.44 (195), 
L5.45 (196), and F5.61 (202) on both CB2 receptors was -14 kcal/mol during the 500 ns 
of MD run in both the trajectories. These results suggest that this hydrophobic patch on 
the TMH5 in the CB2 R/R* homodimer is a stable feature of the homodimer. Further 
experimental mutation studies need to be designed to verify that these TMH5 residues 
form part of the CB2 R/R* homodimer interface. 
The Orientation of Gαi1β1γ2 Heterotrimer Relative to CB2 R/ R* Homodimer 
 There is only one GPCR/ G protein complex (β2 AR / Gαsβ1γ1 complex) that has 
been crystalized to date (32). In addition there is no crystal structure available for any 
GPCR homodimer in complex with their partner heterotrimeric G protein. It is very 
challenging both experimentally and computationally to predict precise orientations of 
the proteins in the GCPR dimer/ G protein complex in a first attempt.  
 In the initial CB2 R/R* / Gαi1β1γ2 complex model, Gαi1β1γ2 was placed under the 
CB2 R/R* homodimer, but during 500 ns simulations, the G-protein changed its 
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orientation in both the trajectories and pulled away from the dimer. This suggests that our 
initial orientation of Gαi1β1γ2  protein relative to CB2 R/R* homodimer was not correct. 
We abandoned this homodimer project when monomeric β2-adrenergic receptor/Gs 
crystal structure became available (32). We reasoned that this structure provided a better 
starting structure for a receptor-G-protein complex. As discussed in Chapter I, this initial 
interface changed in our simulation of the CB2 R*/ Gαi1β1γ2  complex as well, however 
the proteins remained in complex. This was in contrast to what was seen for the CB2 R 
R* homodimer / Gαi1β1γ2  protein complex. As discussed in Chapter I, the change in the 
orientation of Gαi1β1γ2  heterotrimer protein relative to the monomer CB2 in our later 
simulations may better reflect the complex geometry for Gi coupled GPCRs (100). 
Conclusions 
 Result suggested that the extracellular end of TMH6 and hydrophobic patch on 
TMH5 may be involved in the CB2 R R* homodimer interface. The next stage of this 
project will be the experimental verification of the importance of TMH5 residues to the 
dimer interface and additional study of the formation of the CB2 R R* / Gαi1β1γ2 signaling 
complex with a different orientation of Gαi1β1γ2 protein under the CB2 R/ R* homodimer. 
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